Differential	O
regulation	O
of	O
coproporphyrinogen	B-DNA
oxidase	I-DNA
gene	I-DNA
between	O
erythroid	B-cell_type
and	I-cell_type
nonerythroid	I-cell_type
cells	I-cell_type
.	O

Coproporphyrinogen	B-protein
oxidase	I-protein
(	O
CPO	B-protein
)	O
catalyzes	O
the	O
sixth	O
step	O
of	O
the	O
heme	B-protein
biosynthetic	O
pathway	O
.	O

To	O
assess	O
the	O
tissue-specific	O
regulation	O
of	O
the	O
CPO	B-DNA
gene	I-DNA
promoter	I-DNA
,	O
mouse	B-DNA
genomic	I-DNA
DNA	I-DNA
clones	I-DNA
for	O
CPO	B-protein
were	O
isolated	O
.	O

Structural	O
analysis	O
demonstrated	O
that	O
the	O
mouse	B-DNA
CPO	I-DNA
gene	I-DNA
spans	O
approximately	O
11	O
kb	O
and	O
consists	O
of	O
seven	B-DNA
exons	I-DNA
,	O
just	O
like	O
its	O
human	O
counterpart	O
.	O

Functional	O
analysis	O
of	O
the	O
promoter	O
by	O
transient	O
transfection	O
assays	O
indicated	O
that	O
synergistic	O
action	O
between	O
an	O
SP-1-like	B-DNA
element	I-DNA
at	O
-21/-12	O
,	O
a	O
GATA	B-DNA
site	I-DNA
at	O
-59/-54	O
,	O
and	O
a	O
novel	B-DNA
regulatory	I-DNA
element	I-DNA
,	O
CPRE	B-DNA
(	O
-	O
GGACTACAG	B-DNA
-	O
)	O
at	O
-49/-41	O
,	O
is	O
essential	O
for	O
the	O
promoter	O
activity	O
in	O
murine	B-cell_type
erythroleukemia	I-cell_type
(	I-cell_type
MEL	I-cell_type
)	I-cell_type
cells	I-cell_type
.	O

In	O
nonerythroid	B-cell_line
NIH3T3	I-cell_line
cells	I-cell_line
,	O
however	O
,	O
the	O
GATA	B-DNA
site	I-DNA
is	O
not	O
required	O
.	O

Gel	O
mobility	O
shift	O
assays	O
demonstrated	O
that	O
specific	O
DNA-protein	B-protein
complexes	I-protein
can	O
be	O
formed	O
with	O
each	O
element	O
,	O
and	O
that	O
there	O
are	O
cell-specific	O
differences	O
in	O
factors	O
,	O
which	O
bind	O
to	O
the	O
SP-1-like	B-DNA
element	I-DNA
between	O
MEL	B-cell_line
and	I-cell_line
NIH3T3	I-cell_line
cells	I-cell_line
.	O

These	O
results	O
provide	O
evidence	O
for	O
differential	O
regulation	O
of	O
the	O
promoter	O
function	O
of	O
CPO	B-protein
gene	O
between	O
erythroid	B-cell_type
and	I-cell_type
nonerythroid	I-cell_type
cells	I-cell_type
.	O

Copyright	O
1998	O
by	O
The	O
American	O
Society	O
of	O
Hematology	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Differential	NULL
Regulation	NULL
of	NULL
Coproporphyrinogen	NULL
Oxidase	NULL
Gene	NULL
Between	NULL
Erythroid	NULL
and	NULL
Nonerythroid	NULL
Cells	NULL
By	NULL
Shinichiro	NULL
Takahashi	NULL
,	NULL
Shigeru	NULL
Taketani	NULL
,	NULL
Jun-etsu	NULL
Akasaka	NULL
,	NULL
Akira	NULL
Kobayashi	NULL
,	NULL
Norio	NULL
Hayashi	NULL
,	NULL
Masayuki	NULL
Yamamoto	NULL
,	NULL
and	NULL
Tadashi	NULL
Nagai	NULL
Coproporphyrinogen	NULL
oxidase	NULL
(	NULL
CPO	NULL
)	NULL
catalyzes	NULL
the	NULL
sixth	NULL
step	NULL
of	NULL
the	NULL
heme	NULL
biosynthetic	NULL
pathway	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
the	NULL
CPO	NULL
gene	NULL
promoter	NULL
,	NULL
mouse	NULL
genomic	NULL
DNA	NULL
clones	NULL
for	NULL
CPO	NULL
were	NULL
isolated	NULL
.	NULL

Structural	NULL
analysis	NULL
demonstrated	NULL
that	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
spans	NULL
approximately	NULL
11	NULL
kb	NULL
and	NULL
consists	NULL
of	NULL
seven	NULL
exons	NULL
,	NULL
just	NULL
like	NULL
its	NULL
human	NULL
counterpart	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
promoter	NULL
by	NULL
transient	NULL
transfection	NULL
assays	NULL
indicated	NULL
that	NULL
synergistic	NULL
action	NULL
between	NULL
an	NULL
SP-1-like	NULL
element	NULL
at	NULL
-21/-12	NULL
,	NULL
a	NULL
GATA	NULL
site	NULL
at	NULL
-59/	NULL
-54	NULL
,	NULL
and	NULL
a	NULL
novel	NULL
regulatory	NULL
element	NULL
,	NULL
CPRE	NULL
(	NULL
-GGACTA-CAG-	NULL
)	NULL
at	NULL
-49/-41	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
HE	NULL
BIOSYNTHESIS	NULL
OF	NULL
HEME	NULL
is	NULL
differently	NULL
regulated	NULL
between	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cells	NULL
.	NULL

During	NULL
erythroid	NULL
differentiation	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
each	NULL
enzyme	NULL
increases	NULL
sequentially	NULL
,	NULL
beginning	NULL
with	NULL
the	NULL
first	NULL
enzyme	NULL
of	NULL
the	NULL
pathway	NULL
,	NULL
erythroid-specific	NULL
8-aminolevulinate	NULL
synthase	NULL
(	NULL
ALAS-E	NULL
)	NULL
.	NULL

>	NULL
``	NULL
In	NULL
liver	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
under	NULL
conditions	NULL
that	NULL
increase	NULL
the	NULL
rate	NULL
of	NULL
heme	NULL
synthesis	NULL
,	NULL
only	NULL
the	NULL
first	NULL
enzyme	NULL
,	NULL
nonspecific	NULL
(	NULL
housekeep-ing	NULL
)	NULL
ALAS-N	NULL
is	NULL
upregulated	NULL
,	NULL
while	NULL
the	NULL
level	NULL
of	NULL
other	NULL
enzymes	NULL
remains	NULL
unchanged	NULL
.	NULL
``	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
this	NULL
latter	NULL
type	NULL
of	NULL
regulation	NULL
may	NULL
also	NULL
take	NULL
place	NULL
in	NULL
other	NULL
nonerythroid	NULL
tissues	NULL
.	NULL

There	NULL
are	NULL
two	NULL
principal	NULL
reasons	NULL
that	NULL
account	NULL
for	NULL
the	NULL
distinct	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
heme	NULL
synthesis	NULL
.	NULL

The	NULL
first	NULL
is	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
two	NULL
ALAS	NULL
isozymes*	NULL
``	NULL
are	NULL
encoded	NULL
by	NULL
distinct	NULL
genes	NULL
,	NULL
erythroid-specifically	NULL
expressed	NULL
,	NULL
ALAS-E	NULL
,	NULL
and	NULL
nonspe-cific	NULL
,	NULL
ALAS-N	NULL
.	NULL

The	NULL
second	NULL
is	NULL
that	NULL
both	NULL
S-aminolevulinate	NULL
dehydratase	NULL
and	NULL
porphobilinogen	NULL
deaminase	NULL
(	NULL
PBGD	NULL
)	NULL
,	NULL
the	NULL
second	NULL
and	NULL
third	NULL
enzymes	NULL
in	NULL
the	NULL
pathway	NULL
,	NULL
respectively	NULL
,	NULL
are	NULL
transcribed	NULL
from	NULL
two	NULL
distinct	NULL
promoters	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
with	NULL
5'-alternative	NULL
splicing	NULL
.	NULL
``	NULL

However	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
whether	NULL
there	NULL
is	NULL
distinct	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
other	NULL
enzymes	NULL
in	NULL
the	NULL
heme	NULL
biosynthetic	NULL
pathway	NULL
.	NULL

Coproporphyrinogen	NULL
oxidase	NULL
(	NULL
CPO	NULL
,	NULL
EC	NULL
1.3.3.3	NULL
)	NULL
,	NULL
the	NULL
sixth	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Tohoku	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Sendai	NULL
,	NULL
Japan	NULL
;	NULL
Department	NULL
of	NULL
Hygiene	NULL
,	NULL
Kansai	NULL
Medical	NULL
University	NULL
,	NULL
Moriguchi	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
the	NULL
Center	NULL
for	NULL
Tsukuba	NULL
Advanced	NULL
Research	NULL
Alliance	NULL
,	NULL
(	NULL
TARA	NULL
)	NULL
and	NULL
Institute	NULL
of	NULL
Basic	NULL
Medical	NULL
Sciences	NULL
,	NULL
University	NULL
of	NULL
Tsukuba	NULL
,	NULL
Tsukuba	NULL
,	NULL
Japan	NULL
.	NULL

Submitted	NULL
March	NULL
12	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
June	NULL
24	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
Grants-in-Aid	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
Sports	NULL
and	NULL
Culture	NULL
,	NULL
Japan	NULL
(	NULL
to	NULL
N.H.	NULL
,	NULL
M.Y	NULL
.	NULL

,	NULL
and	NULL
TN	NULL
.	NULL
)	NULL

,	NULL
Grant-in-Aid	NULL
for	NULL
Scientific	NULL
Research	NULL
(	NULL
to	NULL
S.T	NULL
.	NULL
)	NULL

,	NULL
and	NULL
Research	NULL
Grant	NULL
from	NULL
Sumitomo	NULL
Chemicals	NULL
Co	NULL
(	NULL
to	NULL
S.T	NULL
.	NULL
)	NULL

.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
data	NULL
reported	NULL
in	NULL
this	NULL
report	NULL
will	NULL
appear	NULL
in	NULL
the	NULL
DDBJ/EMBL/GenBank	NULL
nucleotide	NULL
sequence	NULL
databases	NULL
with	NULL
the	NULL
accession	NULL
numbers	NULL
ABO11237	NULL
to	NULL
ABO11243	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Tadashi	NULL
Nagai	NULL
,	NULL
MD	NULL
,	NULL
PhD	NULL
,	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Tohoku	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
2-1	NULL
Seiryo-machi	NULL
,	NULL
Sendai	NULL
,	NULL
980-77	NULL
,	NULL
Japan	NULL
;	NULL
e-mail	NULL
:	NULL
shintak	NULL
@	NULL
mail.ce.tohoku.ac.jp	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/98/9209-0014	NULL
$	NULL
3.00/0	NULL
3436	NULL
murine	NULL
erythroleukemia	NULL
(	NULL
MEL	NULL
)	NULL
cells	NULL
.	NULL

In	NULL
nonerythroid	NULL
NIH3T3	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
the	NULL
GATA	NULL
site	NULL
is	NULL
not	NULL
required	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
demonstrated	NULL
that	NULL
specific	NULL
DNA-protein	NULL
complexes	NULL
can	NULL
be	NULL
formed	NULL
with	NULL
each	NULL
element	NULL
,	NULL
and	NULL
that	NULL
there	NULL
are	NULL
cell-specific	NULL
differences	NULL
in	NULL
factors	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
the	NULL
SP-1-like	NULL
element	NULL
between	NULL
MEL	NULL
and	NULL
NIH3T3	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
evidence	NULL
for	NULL
differential	NULL
regulation	NULL
of	NULL
the	NULL
promoter	NULL
function	NULL
of	NULL
CPO	NULL
gene	NULL
between	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cells	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

enzyme	NULL
in	NULL
the	NULL
heme	NULL
biosynthetic	NULL
pathway	NULL
,	NULL
catalyzes	NULL
the	NULL
removal	NULL
of	NULL
the	NULL
carboxyl	NULL
group	NULL
and	NULL
two	NULL
hydrogen	NULL
atoms	NULL
from	NULL
the	NULL
propionate	NULL
groups	NULL
at	NULL
positions	NULL
2	NULL
and	NULL
4	NULL
of	NULL
coproporphyrinogen	NULL
III	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
vinyl	NULL
groups	NULL
at	NULL
these	NULL
posi-tions	NULL
.	NULL
``	NULL

The	NULL
mRNA	NULL
level	NULL
and	NULL
activity	NULL
of	NULL
CPO	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
significantly	NULL
increased	NULL
in	NULL
murine	NULL
erythroleukemia	NULL
(	NULL
MEL	NULL
)	NULL
cells	NULL
during	NULL
dimethyl	NULL
sulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
-induced	NULL
erythroid	NULL
cell	NULL
differentiation	NULL
,	NULL
``	NULL
while	NULL
they	NULL
are	NULL
unchanged	NULL
in	NULL
mouse	NULL
liver	NULL
by	NULL
treatment	NULL
with	NULL
2-allyl-2-isopropylacetamide	NULL
,	NULL
despite	NULL
a	NULL
potent	NULL
induction	NULL
of	NULL
ALAS-N	NULL
by	NULL
the	NULL
chemical	NULL
.	NULL
``	NULL

These	NULL
findings	NULL
suggested	NULL
that	NULL
CPO	NULL
expression	NULL
might	NULL
be	NULL
regulated	NULL
in	NULL
a	NULL
different	NULL
manner	NULL
between	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
CPO	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
become	NULL
rate-limiting	NULL
for	NULL
heme	NULL
synthesis	NULL
during	NULL
erythroid	NULL
differentiation	NULL
.	NULL

?	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
clarify	NULL
the	NULL
regulatory	NULL
mechanism	NULL
of	NULL
CPO	NULL
gene	NULL
expression	NULL
and	NULL
its	NULL
role	NULL
in	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Recently	NULL
,	NULL
mouse	NULL
and	NULL
human	NULL
cDNA	NULL
clones	NULL
and	NULL
a	NULL
human	NULL
genomic	NULL
DNA	NULL
clone	NULL
of	NULL
CPO	NULL
were	NULL
isolated	NULL
.	NULL

!	NULL

*	NULL
``	NULL
``	NULL
Structural	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
CPO	NULL
gene	NULL
showed	NULL
that	NULL
it	NULL
consists	NULL
of	NULL
seven	NULL
exons	NULL
spanning	NULL
approximately	NULL
14	NULL
kb	NULL
,	NULL
and	NULL
that	NULL
CPO	NULL
mRNA	NULL
is	NULL
transcribed	NULL
from	NULL
a	NULL
single	NULL
promoter	NULL
both	NULL
in	NULL
erythroid	NULL
and	NULL
in	NULL
nonerythroid	NULL
cells	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
a	NULL
single	NULL
promoter	NULL
may	NULL
regulate	NULL
both	NULL
inducible	NULL
and	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
CPO	NULL
gene	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
CPO	NULL
gene	NULL
between	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
structural	NULL
analysis	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
and	NULL
compared	NULL
its	NULL
promoter	NULL
function	NULL
in	NULL
MEL	NULL
and	NULL
NIH3T3	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
CPRE	NULL
,	NULL
a	NULL
novel	NULL
regulatory	NULL
element	NULL
found	NULL
at	NULL
-49/-41	NULL
,	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
CPO	NULL
gene	NULL
expression	NULL
both	NULL
in	NULL
MEL	NULL
and	NULL
NIH3T3	NULL
cells	NULL
,	NULL
while	NULL
interaction	NULL
with	NULL
GATA-1	NULL
and	NULL
SP-1-like	NULL
element-binding	NULL
protein	NULL
is	NULL
additionally	NULL
necessary	NULL
for	NULL
the	NULL
maximal	NULL
upregulation	NULL
of	NULL
the	NULL
CPO	NULL
gene	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
mouse	NULL
CPO	NULL
genomic	NULL
clones	NULL
.	NULL

-	NULL
The	NULL
129	NULL
SVJ	NULL
mouse	NULL
genomic	NULL
library	NULL
in	NULL
the	NULL
A	NULL
FIXI	NULL
vector	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
screened	NULL
using	NULL
a	NULL
1.4-kb	NULL
EcoRI-digested	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
cDNA	NULL
clone	NULL
containing	NULL
the	NULL
entire	NULL
coding	NULL
region	NULL
as	NULL
a	NULL
probe	NULL
.	NULL
``	NULL

Seven	NULL
independent	NULL
clones	NULL
were	NULL
obtained	NULL
and	NULL
mapped	NULL
.	NULL

Because	NULL
two	NULL
overlapping	NULL
clones	NULL
,	NULL
B6	NULL
and	NULL
B8	NULL
,	NULL
were	NULL
found	NULL
to	NULL
cover	NULL
the	NULL
entire	NULL
mouse	NULL
CPO	NULL
gene	NULL
,	NULL
they	NULL
were	NULL
used	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

Nucleotide	NULL
sequences	NULL
were	NULL
determined	NULL
with	NULL
a	NULL
cycle	NULL
sequencing	NULL
system	NULL
using	NULL
ABI	NULL
377	NULL
sequencer	NULL
(	NULL
Perkin-Elmer	NULL
Corp	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
Vol	NULL
92	NULL
,	NULL
No	NULL
9	NULL
(	NULL
November	NULL
1	NULL
)	NULL
,	NULL
1998	NULL
:	NULL
pp	NULL
3436-3444	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REGULATION	NULL
OF	NULL
MOUSE	NULL
CPO	NULL
GENE	NULL
EXPRESSION	NULL
Identification	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
and	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

The	NULL
transcription	NULL
start	NULL
site	NULL
was	NULL
estimated	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
amplification	NULL
of	NULL
the	NULL
5'-end	NULL
of	NULL
cDNA	NULL
.	NULL

A	NULL
total	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
prepared	NULL
from	NULL
mouse	NULL
liver	NULL
and	NULL
MEL	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
starting	NULL
materials	NULL
,	NULL
with	NULL
5'-rapid	NULL
amplification	NULL
of	NULL
cDNA	NULL
end	NULL
(	NULL
RACE	NULL
)	NULL
amplification	NULL
kit	NULL
(	NULL
GIBCO-BRL	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL
``	NULL

Oligonucleotide	NULL
primers	NULL
complementary	NULL
to	NULL
nucleotides	NULL
-270/-251	NULL
and	NULL
-273/-254	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
cDNA	NULL
``	NULL
were	NULL
used	NULL
for	NULL
the	NULL
first	NULL
strand	NULL
cDNA	NULL
synthesis	NULL
and	NULL
PCR	NULL
amplification	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
isolated	NULL
and	NULL
sequenced	NULL
.	NULL

Cell	NULL
culture	NULL
.	NULL

-	NULL
MEL	NULL
cells	NULL
,	NULL
clone	NULL
745A	NULL
,	NULL
and	NULL
NIH3T3	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
Modified	NULL
Eagle	NULL
Medium	NULL
(	NULL
DMEM	NULL
;	NULL
Nissui	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
and	NULL
split	NULL
every	NULL
3	NULL
days	NULL
.	NULL

For	NULL
preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
,	NULL
cells	NULL
from	NULL
24-	NULL
to	NULL
48-hour-old	NULL
cultures	NULL
were	NULL
resuspended	NULL
in	NULL
the	NULL
fresh	NULL
medium	NULL
at	NULL
a	NULL
density	NULL
of	NULL
5	NULL
X	NULL
10+	NULL
cells/mL	NULL
and	NULL
incubated	NULL
for	NULL
16	NULL
hours	NULL
,	NULL
to	NULL
ascertain	NULL
a	NULL
logarithmic	NULL
cell	NULL
growth	NULL
.	NULL

Then	NULL
DMSO	NULL
was	NULL
added	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

While	NULL
these	NULL
cells	NULL
did	NULL
not	NULL
show	NULL
an	NULL
increase	NULL
in	NULL
benzidine-positive	NULL
cells	NULL
at	NULL
24	NULL
hours	NULL
,	NULL
over	NULL
90	NULL
%	NULL
of	NULL
cells	NULL
became	NULL
benzidine-positive	NULL
when	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
4	NULL
days	NULL
.	NULL

Plasmids	NULL
.	NULL

A	NULL
series	NULL
of	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
promoter	NULL
were	NULL
constructed	NULL
,	NULL
which	NULL
were	NULL
also	NULL
fused	NULL
to	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

First	NULL
,	NULL
various	NULL
DNA	NULL
fragments	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
promoter	NULL
region	NULL
were	NULL
obtained	NULL
by	NULL
PCR	NULL
using	NULL
the	NULL
following	NULL
forward	NULL
primers	NULL
:	NULL
-	NULL
-	NULL
(	NULL
spanning	NULL
positions	NULL
-958	NULL
to	NULL
-935	NULL
)	NULL
,	NULL
5-ACAGCCGGTACCGAAGCTTGTG-3	NULL
'	NULL
(	NULL
-660	NULL
to	NULL
-639	NULL
)	NULL
,	NULL
5'-TAGTTAAAGGGGTACCGAGCCC-3	NULL
'	NULL
(	NULL
-579	NULL
to	NULL
-558	NULL
)	NULL
,	NULL
55-CTTTGGGTACCCCAAGCACAGG-3	NULL
'	NULL
(	NULL
-374	NULL
to	NULL
-353	NULL
)	NULL
,	NULL
5	NULL
``	NULL
-CCACAGGTACCACGAAGACAAG-3	NULL
'	NULL
(	NULL
-330	NULL
to	NULL
-309	NULL
)	NULL
,	NULL
5'-CTAACGGTACCTTTGCTCACTG-3	NULL
'	NULL
(	NULL
-262	NULL
to	NULL
-241	NULL
)	NULL
,	NULL
5'-AAGGGG-TACCTGACTAAAGCGC-3	NULL
'	NULL
(	NULL
-217	NULL
to	NULL
-196	NULL
)	NULL
,	NULL
5	NULL
``	NULL
-GCAGCGGTAC-CCACCTCTGTGC-3	NULL
'	NULL
(	NULL
-135	NULL
to	NULL
-114	NULL
)	NULL
,	NULL
5'-TTTCCGGTAC-CGGTCAGGCGAG-3	NULL
'	NULL
(	NULL
-90	NULL
to	NULL
-69	NULL
)	NULL
,	NULL
5'-CGAGGGTACCAGGC-GATAGGAC-3	NULL
'	NULL
(	NULL
-72	NULL
to	NULL
=-51	NULL
)	NULL
,	NULL
TAC-3	NULL
'	NULL
(	NULL
-64	NULL
to	NULL
-43	NULL
)	NULL
,	NULL
5-GGACGGTACCACAGTTCCCAG-3	NULL
'	NULL
(	NULL
-54	NULL
to	NULL
-34	NULL
)	NULL
,	NULL
5-GCCTGGTACCTACACTCGCAGC-3	NULL
'	NULL
(	NULL
-9	NULL
to	NULL
+13	NULL
)	NULL
,	NULL
and	NULL
the	NULL
acceptor	NULL
primer	NULL
,	NULL
5-ATCTCCAAGGTCCTCGAGGCCC-3	NULL
'	NULL
(	NULL
+50	NULL
to	NULL
+71	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
DNA	NULL
fragments	NULL
were	NULL
digested	NULL
with	NULL
Kpr	NULL
I	NULL
and	NULL
Xho	NULL
I	NULL
and	NULL
inserted	NULL
into	NULL
the	NULL
Kpn	NULL
I/Xho	NULL
I	NULL
site	NULL
of	NULL
the	NULL
pGL3-Basic	NULL
plasmid	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WID	NULL
)	NULL
,	NULL
which	NULL
yielded	NULL
pGL946	NULL
,	NULL
pGL648	NULL
,	NULL
pGL563	NULL
,	NULL
pGL363	NULL
,	NULL
pGL319	NULL
,	NULL
pGL251	NULL
,	NULL
pGL207	NULL
,	NULL
pGL124	NULL
,	NULL
pGL79	NULL
,	NULL
pGL62	NULL
,	NULL
pGL54	NULL
,	NULL
pGL44	NULL
,	NULL
and	NULL
pGL2	NULL
.	NULL

pGL79-Gm	NULL
,	NULL
-Sm	NULL
,	NULL
-GXm	NULL
,	NULL
-51m	NULL
,	NULL
-49m	NULL
,	NULL
-47m	NULL
,	NULL
-45m	NULL
,	NULL
and	NULL
-42m	NULL
were	NULL
created	NULL
with	NULL
Transformer	NULL
site-directed	NULL
mutagenesis	NULL
system	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
the	NULL
following	NULL
mutagenic	NULL
primers	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
nucleotide	NULL
sequences	NULL
of	NULL
mutants	NULL
were	NULL
verified	NULL
by	NULL
sequencing	NULL
:	NULL
5-CGAGTGCAGGAGGCGTAAGGACGG-GACTACAG-3	NULL
'	NULL
,	NULL
5-CCTCCTCGGCTCCcTTCCAGCAGCctTaco-3	NULL
'	NULL
,	NULL
5'-CGAGTGCAGGAGGCGTAAGGACGGGTITACAG-2	NULL
'	NULL
,	NULL
5'-GCAG-GAGGCGATAGGATTGGACTACAGTTCCC-3	NULL
'	NULL
,	NULL
-	NULL
5'-GGAGGC-GATAGGACGTTACTACAGTTCCCAGC-3	NULL
'	NULL
,	NULL
5'-GAGGCGATAG-GACGGGTITACAGTTCCCAGCAG-3	NULL
'	NULL
,	NULL
5'-GCGATAGGACGG-GACACCAGTTCCCAGCAGCC-3	NULL
'	NULL
,	NULL
and	NULL
5'-GATAGGACGGGAC-TACTATTCCCAGCAGCCTCC-3	NULL
'	NULL
.	NULL

TrEsfection	NULL
and	NULL
luciferase	NULL
assays	NULL
.	NULL

-	NULL
A	NULL
total	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
each	NULL
reporter	NULL
plasmid	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
pENL	NULL
'	NULL
(	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
)	NULL
were	NULL
cotransfected	NULL
into	NULL
MEL	NULL
cells	NULL
using	NULL
DOTAP	NULL
(	NULL
N-	NULL
[	NULL
1-	NULL
(	NULL
2,3-dioleoyloxy	NULL
)	NULL
propy1	NULL
]	NULL
-N	NULL
,	NULL
N	NULL
,	NULL
N-trimethylammonium	NULL
methylsulfate	NULL
)	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Corp	NULL
,	NULL
India-napolis	NULL
,	NULL
IN	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Briefly	NULL
,	NULL
a	NULL
total	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
plasmids	NULL
and	NULL
DOTAP	NULL
in	NULL
1	NULL
mL	NULL
of	NULL
DMEM	NULL
without	NULL
serum	NULL
for	NULL
6	NULL
hours	NULL
.	NULL

Then	NULL
2	NULL
mL	NULL
of	NULL
fresh	NULL
DMEM	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
was	NULL
added	NULL
.	NULL

DMSO	NULL
was	NULL
added	NULL
to	NULL
cultures	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
20	NULL
hours	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
harvested	NULL
,	NULL
rinsed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
once	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
75	NULL
uL	NULL
of	NULL
1	NULL
X	NULL
Reporter	NULL
Lysis	NULL
Buffer	NULL
(	NULL
Toyo	NULL
Ink	NULL
,	NULL
Ltd	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
determined	NULL
using	NULL
Luciferase	NULL
Assay	NULL
System	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
normalized	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
B-galacto-	NULL
3437	NULL
sidase	NULL
activities	NULL
,	NULL
which	NULL
were	NULL
determined	NULL
using	NULL
chlorophenol	NULL
red-B-galactopyranoside	NULL
as	NULL
substrate	NULL
.	NULL
'	NULL

''	NULL
NIH3T3	NULL
cells	NULL
were	NULL
also	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
plasmids	NULL
similarly	NULL
.	NULL

NIH3T3	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2.5	NULL
X	NULL
10°	NULL
per	NULL
3	NULL
mL	NULL
of	NULL
DMEM	NULL
in	NULL
a	NULL
40-mm	NULL
dish	NULL
and	NULL
incubated	NULL
for	NULL
18	NULL
hours	NULL
before	NULL
transfection	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Lassar	NULL
et	NULL
al	NULL
``	NULL
``	NULL
with	NULL
minor	NULL
modification	NULL
.	NULL

Briefly	NULL
,	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
pelleted	NULL
,	NULL
resuspended	NULL
in	NULL
1	NULL
mL	NULL
of	NULL
the	NULL
lysis	NULL
buffer	NULL
containing	NULL
10	NULL
mmol/L	NULL
Tris-HC	NULL
]	NULL
(	NULL
pH7.4	NULL
)	NULL
,	NULL
10	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
3	NULL
mmol/L	NULL
MgCl	NULL
»	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
and	NULL
placed	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

After	NULL
centrifuga-tion	NULL
,	NULL
nuclear	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
100	NULL
uL	NULL
of	NULL
20	NULL
mmol/L	NULL
Tris-HCl	NULL
(	NULL
pH7.9	NULL
)	NULL
,	NULL
420	NULL
mmol/L	NULL
KCI	NULL
,	NULL
0.2	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
mmol/L	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
and	NULL
0.1	NULL
mmol/L	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
placed	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
minutes	NULL
,	NULL
and	NULL
centrifuged	NULL
.	NULL

The	NULL
supernatants	NULL
thus	NULL
obtained	NULL
were	NULL
used	NULL
as	NULL
nuclear	NULL
extracts	NULL
for	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
using	NULL
a	NULL
Protein	NULL
Assay	NULL
Kit	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

DNA	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

-	NULL
The	NULL
following	NULL
oligomers	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
for	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
:	NULL
CPRE	NULL
,	NULL
5-ATAGGACGGGAC-TACAGTTCC-3	NULL
'	NULL
;	NULL
GATA	NULL
,	NULL
5-TGCAGGAGGCGATAGGACGGGACT-3	NULL
'	NULL
;	NULL
SP-1-like	NULL
,	NULL
5-CTCCTCGGCTCCCGCCAGCAGCCTGC-3	NULL
'	NULL
,	NULL
corresponding	NULL
to	NULL
nucleotides	NULL
-57	NULL
to	NULL
-36	NULL
,	NULL
-68	NULL
to	NULL
-44	NULL
and	NULL
-29	NULL
to	NULL
-4	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
,	NULL
respectively	NULL
.	NULL

For	NULL
SP-1	NULL
,	NULL
5'-GGACTTTATGGGGGC-GGGGCTAAAGGAGGG-3	NULL
'	NULL
was	NULL
used	NULL
,	NULL
which	NULL
included	NULL
the	NULL
consensus	NULL
SP-1	NULL
binding	NULL
site	NULL
.	NULL

Oligomers	NULL
were	NULL
end-labeled	NULL
with	NULL
[	NULL
y-	NULL
>	NULL
2P	NULL
]	NULL
adenosine	NULL
triphosphate	NULL
(	NULL
ATP	NULL
)	NULL
by	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Corp	NULL
)	NULL
.	NULL

The	NULL
antisense	NULL
oligomer	NULL
was	NULL
then	NULL
added	NULL
to	NULL
the	NULL
*P-end-labeled	NULL
oligomer	NULL
to	NULL
yield	NULL
a	NULL
double-stranded	NULL
probe	NULL
.	NULL

A	NULL
total	NULL
of	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
was	NULL
incubated	NULL
in	NULL
a	NULL
reaction	NULL
mixture	NULL
containing	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
buffer	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
60	NULL
mmol/L	NULL
KCI	NULL
,	NULL
0.2	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
6	NULL
mmol/L	NULL
MgCl	NULL
»	NULL
,	NULL
0.5	NULL
mmol/L	NULL
DTT	NULL
,	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
,	NULL
and	NULL
1.5	NULL
ug	NULL
of	NULL
an	NULL
equimolar	NULL
mixture	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
poly	NULL
(	NULL
dA-dT	NULL
)	NULL
with	NULL
a	NULL
``	NULL
P-labeled	NULL
oligomer	NULL
for	NULL
15	NULL
minutes	NULL
on	NULL
ice	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
the	NULL
following	NULL
oligomers	NULL
were	NULL
used	NULL
as	NULL
double-stranded	NULL
forms	NULL
:	NULL
AEGATA	NULL
,	NULL
5'-TTTGGGTTTTATCTCTAGCAAGG-3	NULL
'	NULL
(	NULL
corresponding	NULL
to	NULL
nucleotides	NULL
-135	NULL
to	NULL
-113	NULL
of	NULL
the	NULL
human	NULL
ALAS-E	NULL
gene	NULL
)	NULL
;	NULL
AECACCC	NULL
,	NULL
5-CCGCAGAAGGCAGGGTGGGTGGG-3	NULL
'	NULL
(	NULL
corresponding	NULL
to	NULL
nucleotides	NULL
-73	NULL
to	NULL
-51	NULL
of	NULL
the	NULL
human	NULL
ALAS-E	NULL
gene	NULL
)	NULL
;	NULL
and	NULL
CPREm	NULL
,	NULL
5'-ATAGGACGAGTTAATAATTCC-3	NULL
'	NULL
(	NULL
mutated	NULL
CPRE	NULL
containing	NULL
6	NULL
transversions	NULL
in	NULL
-49/-41	NULL
)	NULL
.	NULL

For	NULL
supershift	NULL
assays	NULL
,	NULL
3	NULL
uL	NULL
of	NULL
anti-GATA-1	NULL
(	NULL
N6	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
then	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
electrophoresed	NULL
at	NULL
150	NULL
V	NULL
at	NULL
4°C	NULL
.	NULL

RESULTS	NULL
Isolation	NULL
of	NULL
mouse	NULL
CPO	NULL
gene	NULL
.	NULL

To	NULL
clarify	NULL
the	NULL
regulatory	NULL
mechanism	NULL
of	NULL
CPO	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
first	NULL
isolated	NULL
genomic	NULL
DNA	NULL
clones	NULL
,	NULL
which	NULL
encode	NULL
mouse	NULL
CPO	NULL
protein	NULL
from	NULL
a	NULL
mouse	NULL
liver	NULL
genomic	NULL
DNA	NULL
library	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
,	NULL
two	NULL
overlapping	NULL
clones	NULL
,	NULL
termed	NULL
B6	NULL
and	NULL
B8	NULL
,	NULL
were	NULL
isolated	NULL
,	NULL
which	NULL
contained	NULL
the	NULL
entire	NULL
gene	NULL
including	NULL
approximately	NULL
up	NULL
to	NULL
4	NULL
kb	NULL
of	NULL
the	NULL
5'-upstream	NULL
region	NULL
.	NULL

The	NULL
organization	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
was	NULL
determined	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
using	NULL
cDNA	NULL
probes	NULL
corresponding	NULL
to	NULL
various	NULL
parts	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
mRNA	NULL
,	NULL
and	NULL
the	NULL
sequence	NULL
of	NULL
each	NULL
exon-intron	NULL
junction	NULL
was	NULL
also	NULL
determined	NULL
.	NULL

This	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
consists	NULL
of	NULL
a	NULL
total	NULL
of	NULL
seven	NULL
exons	NULL
,	NULL
which	NULL
spans	NULL
approximately	NULL
11	NULL
kb	NULL
.	NULL

The	NULL
last	NULL
exon	NULL
(	NULL
exon	NULL
7	NULL
)	NULL
includes	NULL
a	NULL
large	NULL
3'-untranslated	NULL
region	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

The	NULL
length	NULL
of	NULL
the	NULL
introns	NULL
varies	NULL
from	NULL
652	NULL
bp	NULL
to	NULL
2.4	NULL
kb	NULL
,	NULL
and	NULL
all	NULL
exon-intron	NULL
boundaries	NULL
conform	NULL
completely	NULL
to	NULL
the	NULL
GT/AG	NULL
rule	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Genomic	NULL
DNA	NULL
blot	NULL
hybridization	NULL
analysis	NULL
demon	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3438	NULL
TAKAHASHI	NULL
ET	NULL
AL	NULL
B6	NULL
phage	NULL
B8	NULL
phage	NULL
C	NULL
Fig	NULL
1	NULL
.	NULL

Struct	NULL
d	NULL
i	NULL
Two	NULL
overlapping	NULL
|	NULL
phage	NULL
clones	NULL
[	NULL
Jul	NULL
Jal	NULL
)	NULL
'	NULL
(	NULL
B6	NULL
and	NULL
B8	NULL
)	NULL
were	NULL
analyzed	NULL
.	NULL

The	NULL
.	NULL

boxes	NULL
show	NULL
the	NULL
relative	NULL
sizes	NULL
human	NULL
CPO	NULL
gene	NULL
exonl	NULL
2	NULL
83	NULL
4	NULL
°	NULL
6	NULL
7	NULL
and	NULL
positions	NULL
of	NULL
each	NULL
exon	NULL
in	NULL
the	NULL
mouse	NULL
genome	NULL
.	NULL

Solid	NULL
and	NULL
shaded	NULL
boxes	NULL
indicate	NULL
protein	NULL
Hind	NULL
IH	NULL
a	NULL
|	NULL
W	NULL
coding	NULL
and	NULL
untranslated	NULL
regions	NULL
,	NULL
ReoR	NULL
I	NULL
L_	NULL
|	NULL
respectively	NULL
.	NULL

Recognition	NULL
sites	NULL
for	NULL
enzymes	NULL
Hindlll	NULL
,	NULL
EcoRl	NULL
,	NULL
and	NULL
Sac	NULL
I	NULL
l	NULL
B	NULL
Sad	NULL
are	NULL
shown	NULL
.	NULL

Lower	NULL
lines	NULL
.	NULL

show	NULL
restriction	NULL
endonuclease	NULL
Iﬁl	NULL
cleavage	NULL
sites	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

strated	NULL
that	NULL
the	NULL
mouse	NULL
CPO	NULL
is	NULL
specified	NULL
by	NULL
a	NULL
single	NULL
genomic	NULL
locus	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Sequencing	NULL
analysis	NULL
of	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
regulatory	NULL
mechanism	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
5'-upstream	NULL
region	NULL
up	NULL
to	NULL
~1,200	NULL
bp	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Notable	NULL
features	NULL
in	NULL
this	NULL
region	NULL
are	NULL
12	NULL
putative	NULL
GATA	NULL
motives	NULL
that	NULL
contain	NULL
the	NULL
sequence	NULL
nGATAn	NULL
,	NULL
and	NULL
four	NULL
CACCC	NULL
elements	NULL
with	NULL
no	NULL
obvious	NULL
TATA	NULL
or	NULL
CAAT	NULL
boxes	NULL
.	NULL

An	NULL
SP-1	NULL
consensus-like	NULL
sequence	NULL
,	NULL
CTCCCGCCAG	NULL
,	NULL
was	NULL
found	NULL
near	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
these	NULL
cis-elements	NULL
as	NULL
well	NULL
as	NULL
their	NULL
spatial	NULL
arrangement	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
CPO	NULL
gene	NULL
,	NULL
``	NULL
``	NULL
which	NULL
contains	NULL
four	NULL
GATA	NULL
motives	NULL
,	NULL
six	NULL
putative	NULL
SP-1	NULL
binding	NULL
sites	NULL
,	NULL
and	NULL
two	NULL
CACCC	NULL
elements	NULL
within	NULL
a	NULL
786-bp	NULL
region	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

A	NULL
novel	NULL
regulatory	NULL
element	NULL
found	NULL
at	NULL
-49/-41	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
mouse	NULL
CPO	NULL
promoter	NULL
activity	NULL
in	NULL
NIH3T3	NULL
cells	NULL
.	NULL

-	NULL
To	NULL
clarify	NULL
the	NULL
regulatory	NULL
elements	NULL
for	NULL
constitutive	NULL
CPO	NULL
gene	NULL
expression	NULL
in	NULL
nonerythroid	NULL
cells	NULL
,	NULL
transient	NULL
transfection	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
NIH3T3	NULL
cells	NULL
using	NULL
a	NULL
nested	NULL
series	NULL
of	NULL
promoter	NULL
deletion	NULL
constructs	NULL
fused	NULL
to	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
3	NULL
,	NULL
p946	NULL
demonstrated	NULL
a	NULL
high	NULL
level	NULL
of	NULL
the	NULL
reporter	NULL
activity	NULL
.	NULL

The	NULL
removal	NULL
of	NULL
the	NULL
sequence	NULL
between	NULL
-946	NULL
and	NULL
-54	NULL
,	NULL
where	NULL
all	NULL
GATA	NULL
and	NULL
CACCC	NULL
sites	NULL
are	NULL
found	NULL
,	NULL
did	NULL
not	NULL
significantly	NULL
change	NULL
the	NULL
activity	NULL
.	NULL

A	NULL
further	NULL
deletion	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
from	NULL
-54	NULL
to	NULL
-44	NULL
,	NULL
however	NULL
,	NULL
caused	NULL
a	NULL
markedly	NULL
decreased	NULL
activity	NULL
.	NULL

Essentially	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
H4IIE	NULL
cells	NULL
,	NULL
a	NULL
rat	NULL
hepatocellular	NULL
carcinoma-derived	NULL
cell	NULL
line	NULL
,	NULL
were	NULL
used	NULL
instead	NULL
of	NULL
NIH3T3	NULL
cells	NULL
in	NULL
the	NULL
transfection	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
there	NULL
may	NULL
be	NULL
a	NULL
hitherto	NULL
unrecognized	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
region	NULL
between	NULL
-54	NULL
and	NULL
-44	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
question	NULL
,	NULL
various	NULL
constructs	NULL
in	NULL
which	NULL
point	NULL
mutations	NULL
were	NULL
inserted	NULL
into	NULL
this	NULL
region	NULL
were	NULL
generated	NULL
and	NULL
transfected	NULL
into	NULL
NIH3T3	NULL
cells	NULL
.	NULL

Nucleotide	NULL
substitutions	NULL
at	NULL
-49	NULL
and	NULL
-48	NULL
(	NULL
p49m	NULL
)	NULL
and	NULL
at	NULL
-42	NULL
and	NULL
-41	NULL
(	NULL
p42m	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
moderate	NULL
decrease	NULL
in	NULL
the	NULL
reporter	NULL
activity	NULL
(	NULL
~60	NULL
%	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
p79	NULL
)	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
insertions	NULL
at	NULL
-47	NULL
and	NULL
-46	NULL
(	NULL
p47m	NULL
)	NULL
and	NULL
at	NULL
-45	NULL
and	NULL
-44	NULL
(	NULL
p45m	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
the	NULL
reporter	NULL
activity	NULL
(	NULL
to	NULL
>	NULL
~20	NULL
%	NULL
and	NULL
~30	NULL
%	NULL
of	NULL
that	NULL
represented	NULL
by	NULL
p79	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
while	NULL
mutations	NULL
at	NULL
-51	NULL
and	NULL
-50	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
nucleotide	NULL
sequence	NULL
,	NULL
GGACTACAG	NULL
,	NULL
which	NULL
we	NULL
termed	NULL
CPRE	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
promoter	NULL
function	NULL
in	NULL
NIH3T3	NULL
cells	NULL
.	NULL

The	NULL
removal	NULL
of	NULL
a	NULL
region	NULL
between	NULL
-44	NULL
and	NULL
-2	NULL
,	NULL
which	NULL
contained	NULL
an	NULL
SP-l-like	NULL
element	NULL
,	NULL
CTCCCGCCAG	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
further	NULL
decrease	NULL
in	NULL
the	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
SP-1-like	NULL
element	NULL
for	NULL
the	NULL
promoter	NULL
activity	NULL
was	NULL
substantiated	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
p79Sm	NULL
,	NULL
a	NULL
mutated	NULL
p79	NULL
,	NULL
had	NULL
a	NULL
significantly	NULL
decreased	NULL
reporter	NULL
activity	NULL
(	NULL
~60	NULL
%	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
p79	NULL
)	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

p798	NULL
Xm	NULL
,	NULL
double	NULL
mutations	NULL
in	NULL
the	NULL
CPRE	NULL
,	NULL
and	NULL
the	NULL
SP-1-like	NULL
element	NULL
depressed	NULL
the	NULL
promoter	NULL
activity	NULL
more	NULL
than	NULL
did	NULL
p79Xm	NULL
,	NULL
and	NULL
p79Sm	NULL
,	NULL
a	NULL
single	NULL
mutation	NULL
construct	NULL
of	NULL
CPRE	NULL
and	NULL
SP-1-like	NULL
element	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
CPRE	NULL
at	NULL
-49/-41	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
that	NULL
the	NULL
SP-1l-like	NULL
element	NULL
at	NULL
-21/-12	NULL
also	NULL
additionally	NULL
contributes	NULL
to	NULL
the	NULL
promoter	NULL
function	NULL
.	NULL

Functional	NULL
studies	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
promoter	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

CPO	NULL
gene	NULL
expression	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
increase	NULL
significantly	NULL
during	NULL
erythroid	NULL
differentiation	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL
``	NULL

As	NULL
Table	NULL
1	NULL
.	NULL

Intron	NULL
Boundary	NULL
Sequences	NULL
of	NULL
the	NULL
Mouse	NULL
CPO	NULL
Gene	NULL
Exon	NULL
Exon	NULL
Intron	NULL
Intron	NULL
No	NULL
.	NULL

Size	NULL
(	NULL
bp	NULL
)	NULL
Exon-Intron	NULL
Boundaries	NULL
Size	NULL
(	NULL
bp	NULL
)	NULL
No	NULL
.	NULL

1	NULL
636	NULL
AGGAAAGAA	NULL
gtgaggagag	NULL
~1,700	NULL
1	NULL
2	NULL
145	NULL
ctatggacag	NULL
AGATAGTAA	NULL
gtcegataac	NULL
652	NULL
2	NULL
3	NULL
111	NULL
aattttccag	NULL
GTAATTIGCCA	NULL
AAGCTGACG	NULL
gtaagetttg	NULL
~2,400	NULL
3	NULL
4	NULL
142	NULL
getttcatag	NULL
GTAACACACA	NULL
TAAAAAATG	NULL
gtgagetgte	NULL
~700	NULL
4	NULL
5	NULL
219	NULL
ceogttctag	NULL
GTGTGACGAC	NULL
cAcAccece	NULL
gtgagtgaca	NULL
~1,400	NULL
5	NULL
6	NULL
105	NULL
tttctgacag	NULL
GTATGTIGGAG	NULL
GACAGCAAG	NULL
gtaagaaget	NULL
~1,000	NULL
6	NULL
7	NULL
1,534	NULL
acatgegtag	NULL
ATGGGAGTAC	NULL
CCAAATAAA	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REGULATION	NULL
OF	NULL
MOUSE	NULL
CPO	NULL
GENE	NULL
EXPRESSION	NULL
-1131	NULL
GGATTCCAGT	NULL
AAGCACTGAA	NULL
AMTTAAGATT	NULL
AGGGGGGATT	NULL
CAGGGAACAG	NULL
GAGGGGGGAA	NULL
-1131	NULL
ATCCAAACGG	NULL
GTGGAAGTTA	NULL
GTARAACAMT	NULL
TTGTTCGGGG	NULL
TAMGTAMAAC	NULL
AMATAGTTAT	NULL
-1071	NULL
TTGTCTGGGC	NULL
AAGTTPCTTG	NULL
AMTTRCCCAT	NULL
TTGGTPATTC	NULL
TTGGTAGCTT	NULL
CACATTAGCA	NULL
-1011	NULL
GAGCAGGATC	NULL
ATAAAGCGAGA	NULL
AGTTTTTTAC	NULL
AGAMAMAATTAG	NULL
AGAMGATTCCT	NULL
TTTCGTTAAA	NULL
-351	NULL
GRGCTRCATT	NULL
TATCACCAGG	NULL
AGGCCCAGCC	NULL
AGACCCAGGC	NULL
AMCCTTCCAA	NULL
AMGATAATTC	NULL
cara	NULL
-B91	NULL
TEATCPTTCC	NULL
TPPTOTMCCA	NULL
AGTGGGCTTC	NULL
CAGCCAGGEC	NULL
ACACTACAGC	NULL
TAAAAGTTAA	NULL
-B31	NULL
GGGTPTPETCT	NULL
CCTCPGCAAG	NULL
CTTTGTCACT	NULL
TTTCGTGAAT	NULL
TCATTTGCGT	NULL
GCCACATCTG	NULL
-771	NULL
CCAGGCCTGA	NULL
GCACGCATGC	NULL
TGCTCCAGGT	NULL
AGTTTGTGGT	NULL
TGCATTTGTG	NULL
TAMGAAGCAG	NULL
-711	NULL
GEGAGTGAAC	NULL
ATATCGGTCA	NULL
GAMCCATACC	NULL
CAGTGAGCTC	NULL
CAATTCCTGC	NULL
TACAGCCAGA	NULL
~651	NULL
ATGGAAGCTT	NULL
GTGARAGAAT	NULL
AACCAGGGCC	NULL
TCGATTATTA	NULL
TPPTGTTGGT	NULL
AGAMATTACC	NULL
-591	NULL
ATECTECAAG	NULL
GATAGTTAMA	NULL
GGGCAAATGA	NULL
CCCCTTTCTG_ATACTATAAA	NULL
ATAMMGTGG	NULL
-531	NULL
CAATGATATA	NULL
TGCTTGGAAC	NULL
AMAACTATTA	NULL
AATGTGTGAG	NULL
TTTCTGTCTT	NULL
CATMTTTTCA	NULL
-471	NULL
AACGGGTAGG	NULL
GTATGGGGAA	NULL
CAACAGACAT	NULL
CCAGGATAGT	NULL
AAACCGGAGT	NULL
CCCAATATTT	NULL
-411	NULL
TPPTTIGGAT	NULL
CTATTCAGGA	NULL
GCCCACTACC	NULL
TGGGTAAGCC	NULL
AAGCACAGGG	NULL
-351	NULL
ACAMGGGTGC	NULL
ATCCTCCAGA	NULL
CCCACRGCCA	NULL
GGACGAAGAC	NULL
AAGGG	NULL
@	NULL
TGTG	NULL
TCTCTGAGTT	NULL
-291	NULL
GTTATTICTG	NULL
CCCGTTRGTC	NULL
GTCMGCCTTC	NULL
TAMCCCCACT	NULL
TTRECTCACT	NULL
oréceTeacc	NULL
-231	NULL
GAGCAGGGCA	NULL
ATCCAAGGTG	NULL
TACGTGACTA	NULL
AAGCGCC	NULL
TRATCAGTC	NULL
CAMGCACCTC	NULL
cajoa	NULL
-171	NULL
CACAMGTCCTC	NULL
TGGCAGCACA	NULL
GEMGGCCCGC	NULL
@	NULL
TECGMGCAG	NULL
CAGGACCCAC	NULL
CTCTeTrecec	NULL
-111	NULL
AGGGTGcAGt	NULL
CTPMCTGCT	NULL
CTTPCCGGGA	NULL
GCGGTCAGGC	NULL
GAGTGCAGGA	NULL
GGCGATAGGA	NULL
1	NULL
ilar	NULL
-51	NULL
CGGGMCTACA	NULL
eTRCCCaGcA	NULL
Gectcorces	NULL
caccorecea	NULL
ccracacrce	NULL
|	NULL
10	NULL
CAGCAGCTCT	NULL
PCCGAACTCC	NULL
ACGTAGCRGT	NULL
GCTGGGGAGT	NULL
GGGCTOTCAG	NULL
CACCTTGGAG	NULL
70	NULL
Amcceeress	NULL
rerecaecat	NULL
CocaritGee	NULL
cactcooeee	NULL
cocaeareee	NULL
Crteceects	NULL
130	NULL
Geccecerse	NULL
errcegacee	NULL
ACGeTeeree	NULL
Tcascrecec	NULL
190	NULL
@	NULL
ccecercee	NULL
cececrecee	NULL
erccecccec	NULL
TECeTeecac	NULL
Gecreercec	NULL
250	NULL
CaTCCrCGce	NULL
GcéecCmeee	NULL
CTaCTGCCCC	NULL
GCedereede	NULL
Gcrececace	NULL
310	NULL
creemaecce	NULL
Ccacactese	NULL
CooctGecar	NULL
CCCoo0oTtt	NULL
370	NULL
RGcesece	NULL
@	NULL
a	NULL
AMTGGTecce	NULL
CaGgAGCTCeG	NULL
GGecccedat	NULL
CCootoacer	NULL
Gcactocdee	NULL
430	NULL
mecacercee	NULL
eccosceeor	NULL
ccrecacert	NULL
cateroorce	NULL
cceqtcacce	NULL
490	NULL
RGCTGCGGGA	NULL
GCTECGGAGG	NULL
AGGCCCGGAGG	NULL
ACATGRACAC	NULL
CAAGATGCAG	NULL
CTCAMTGATTA	NULL
550	NULL
TGeaGaCCca	NULL
Cectcacere	NULL
TTTATTGCGT	NULL
Tecccacrrc	NULL
610	NULL
ACTGTGGACC	NULL
GGTEGGAGAG	NULL
GAAMGAAgtq	NULL
aggagagage	NULL
tccagotttt	NULL
qttcectcta	NULL
670	NULL
gtgagggttt	NULL
attgecogot	NULL
tqggegtaate	NULL
atgqtcatty	NULL
ctgtttcoct	NULL
qgtgtgaaatt	NULL
730	NULL
gttaatcoge	NULL
tcocaattee	NULL
tcaccaceta	NULL
cgaaccegga	NULL
agccttatgt	NULL
qttaagecty	NULL
Fig	NULL
2	NULL
.	NULL

The	NULL
5'-upstream	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
(	NULL
uppercase	NULL
letters	NULL
)	NULL
and	NULL
5	NULL
'	NULL
-upstream	NULL
regions	NULL
(	NULL
-1.2	NULL
kb	NULL
)	NULL
is	NULL
demonstrated	NULL
.	NULL

White	NULL
and	NULL
black	NULL
arrows	NULL
indicate	NULL
the	NULL
major	NULL
and	NULL
the	NULL
minor	NULL
transcription	NULL
initiation	NULL
sites	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
putative	NULL
cis-acting	NULL
GATA	NULL
,	NULL
CACCC	NULL
,	NULL
and	NULL
SP-1-like	NULL
elements	NULL
are	NULL
boxed	NULL
and	NULL
underlined	NULL
.	NULL

The	NULL
initiating	NULL
codon	NULL
is	NULL
show	NULL
n	NULL
in	NULL
bold	NULL
and	NULL
underlined	NULL
.	NULL

The	NULL
intronic	NULL
sequence	NULL
is	NULL
expressed	NULL
in	NULL
lowercase	NULL
letters	NULL
.	NULL

shown	NULL
in	NULL
Fig	NULL
5	NULL
,	NULL
p946	NULL
conferred	NULL
a	NULL
70-fold	NULL
higher	NULL
transcription	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
compared	NULL
with	NULL
pGL3Basic	NULL
,	NULL
a	NULL
promoter-less	NULL
luciferase	NULL
reporter	NULL
construct	NULL
.	NULL

Treatment	NULL
with	NULL
DMSO	NULL
,	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
erythroid	NULL
differentiation	NULL
of	NULL
MEL	NULL
cells	NULL
,	NULL
elicited	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
,	NULL
while	NULL
the	NULL
same	NULL
treatment	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
activity	NULL
in	NULL
NIH3T3	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
promoter	NULL
activity	NULL
is	NULL
946	NULL
3439	NULL
increased	NULL
during	NULL
erythroid	NULL
differentiation	NULL
of	NULL
MEL	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
nonerythroid	NULL
cells	NULL
such	NULL
as	NULL
NIH3T3	NULL
cells	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
both	NULL
basal	NULL
and	NULL
DMSO-induced	NULL
luciferase	NULL
activities	NULL
remained	NULL
unaffected	NULL
by	NULL
the	NULL
removal	NULL
of	NULL
a	NULL
sequence	NULL
between	NULL
-946	NULL
and	NULL
-54	NULL
,	NULL
which	NULL
contains	NULL
12	NULL
GATA	NULL
sites	NULL
and	NULL
four	NULL
CACCC	NULL
elements	NULL
.	NULL

Further	NULL
deletion	NULL
from	NULL
-54	NULL
to	NULL
-44	NULL
,	NULL
however	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
decrease	NULL
both	NULL
in	NULL
the	NULL
basal	NULL
and	NULL
in	NULL
DMSO-induced	NULL
luciferase	NULL
activities	NULL
,	NULL
and	NULL
the	NULL
removal	NULL
of	NULL
a	NULL
sequence	NULL
between	NULL
-44	NULL
and	NULL
-2	NULL
caused	NULL
a	NULL
further	NULL
loss	NULL
of	NULL
activity	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
CPRE	NULL
at	NULL
-49/-41	NULL
and	NULL
the	NULL
SP-1-like	NULL
element	NULL
at	NULL
-21/-12	NULL
may	NULL
also	NULL
be	NULL
important	NULL
for	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

Because	NULL
our	NULL
previous	NULL
studies	NULL
showed	NULL
that	NULL
a	NULL
GATA	NULL
site	NULL
near	NULL
the	NULL
SP-1-like	NULL
element	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
human	NULL
CPO	NULL
gene	NULL
upregulation	NULL
,	NULL
``	NULL
``	NULL
this	NULL
question	NULL
was	NULL
examined	NULL
in	NULL
detail	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
various	NULL
mutated	NULL
constructs	NULL
containing	NULL
nucleotide	NULL
substitutions	NULL
were	NULL
generated	NULL
from	NULL
p79	NULL
,	NULL
transfected	NULL
into	NULL
MEL	NULL
cells	NULL
,	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
determined	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

A	NULL
mutation	NULL
in	NULL
the	NULL
GATA	NULL
site	NULL
(	NULL
p79Gm	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
promoter	NULL
activity	NULL
,	NULL
although	NULL
it	NULL
abrogated	NULL
formation	NULL
of	NULL
the	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
CPRE	NULL
(	NULL
p79Xm	NULL
)	NULL
decreased	NULL
luciferase	NULL
activity	NULL
(	NULL
>	NULL
60	NULL
%	NULL
of	NULL
that	NULL
generated	NULL
by	NULL
the	NULL
wild-type	NULL
p79	NULL
)	NULL
,	NULL
and	NULL
inhibition	NULL
was	NULL
markedly	NULL
pronounced	NULL
when	NULL
the	NULL
GATA	NULL
site	NULL
was	NULL
also	NULL
mutated	NULL
.	NULL

p79Sm	NULL
,	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
SP-1-like	NULL
element	NULL
alone	NULL
,	NULL
significantly	NULL
decreased	NULL
the	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
p79GSm	NULL
and	NULL
p79SXm	NULL
,	NULL
a	NULL
second	NULL
mutation	NULL
in	NULL
the	NULL
GATA	NULL
site	NULL
,	NULL
and	NULL
CPRE	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
SP-1-like	NULL
element	NULL
is	NULL
essential	NULL
for	NULL
basic	NULL
expression	NULL
,	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
full	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
and	NULL
that	NULL
there	NULL
may	NULL
be	NULL
synergistic	NULL
regulation	NULL
of	NULL
the	NULL
promoter	NULL
function	NULL
among	NULL
these	NULL
elements	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
three	NULL
regulatory	NULL
elements	NULL
was	NULL
then	NULL
examined	NULL
during	NULL
erythroid	NULL
cell	NULL
differentiation	NULL
of	NULL
MEL	NULL
cells	NULL
by	NULL
DMSO	NULL
treatment	NULL
.	NULL

p79GXm	NULL
and	NULL
p79GSm	NULL
,	NULL
which	NULL
did	NULL
not	NULL
contain	NULL
GATA	NULL
,	NULL
but	NULL
contained	NULL
the	NULL
SP-1-like	NULL
element	NULL
and	NULL
CPRE	NULL
,	NULL
respectively	NULL
,	NULL
demonstrated	NULL
only	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
after	NULL
DMSO	NULL
treatment	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
p79SXm	NULL
,	NULL
which	NULL
contained	NULL
the	NULL
GATA	NULL
site	NULL
,	NULL
but	NULL
not	NULL
SP-1-like	NULL
element	NULL
and	NULL
CPRE	NULL
,	NULL
showed	NULL
a	NULL
twofold	NULL
increase	NULL
in	NULL
the	NULL
luciferase	NULL
activity	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
by	NULL
p79	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
GATA	NULL
site	NULL
at	NULL
-59/-54	NULL
plays	NULL
also	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
DMSO-mediated	NULL
+58	NULL
Relative	NULL
luciferase	NULL
activity	NULL
Fig	NULL
3	NULL
.	NULL

Transient	NULL
mouse	NULL
CPO	NULL
gene	NULL
promoter	NULL
activity	NULL
in	NULL
NIH3T3	NULL
cells	NULL
.	NULL

A	NULL
series	NULL
of	NULL
5'-deletion	NULL
mutants	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
promoter	NULL
were	NULL
assayed	NULL
for	NULL
lucif-	NULL
[	NULL
cara	NULL
erase	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
are	NULL
I	NULL
cacee	NULL
expressed	NULL
as	NULL
ratios	NULL
to	NULL
that	NULL
ob-	NULL
N	NULL
[	NULL
J	NULL
SP1	NULL
ike	NULL
tained	NULL
with	NULL
a	NULL
pGL3-Basic	NULL
plasmid	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
values	NULL
from	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

p363	NULL
h	NULL
-s63	NULL
0	NULL
100	NULL
200	NULL
300	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

TAKAHASHI	NULL
ET	NULL
AL	NULL
Relative	NULL
luciferase	NULL
activity	NULL
3440	NULL
A	NULL
ééGGGACTACAGTfa-g	NULL
p79	NULL
-	NULL
QGG	NULL
GACTACAGTT-	NULL
p5lm	NULL
-6TGGGACTACAGTT-	NULL
p49m	NULL
-CG	NULL
&	NULL
}	NULL
éQ1	NULL
‘	NULL
ACAGT	NULL
’	NULL
F-	NULL
p47m	NULL
-	NULL
(	NULL
'	NULL
)	NULL
GGGIE¢L§CAGTT-	NULL
p45m	NULL
-CGGGA-\C§rfujﬁ1	NULL
‘	NULL
T	NULL
.	NULL

p42m	NULL
TA	NULL
a	NULL
B	NULL
GATA	NULL
_	NULL
CPRE	NULL
-	NULL
SP1	NULL
like	NULL
(	NULL
-59/-54	NULL
)	NULL
(	NULL
-49/-41	NULL
)	NULL
(	NULL
21/12	NULL
)	NULL
Relative	NULL
luciferase	NULL
activity	NULL
-19	NULL
p79	NULL
LUC	NULL
p79Gm	NULL
I	NULL
I	NULL
p79Xm	NULL
[	NULL
U	NULL
tsa	NULL
.	NULL

*	NULL
fill	NULL
oma	NULL
2	NULL
—l—l—-—|—-	NULL
X	NULL
p79GXm	NULL
p79Sm	NULL
I	NULL
p	NULL
p79SXm	NULL
U	NULL
o	NULL
y	NULL
's	NULL
‘	NULL
Y-	NULL
X	NULL
79GS	NULL
mculll	NULL
..	NULL
100	NULL
200	NULL
Fig	NULL
4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Identification	NULL
of	NULL
CPRE	NULL
by	NULL
functional	NULL
assays	NULL
in	NULL
NIH3T3	NULL
cells	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
nucleotide	NULL
transversions	NULL
in	NULL
the	NULL
region	NULL
between	NULL
-51	NULL
and	NULL
-40	NULL
were	NULL
ex-amined	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
ratios	NULL
of	NULL
luciferase	NULL
activities	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
a	NULL
pGL3-Basic	NULL
plasmid	NULL
.	NULL

Data	NULL
are	NULL
the	NULL
means	NULL
of	NULL
triplicate	NULL
deter-minations	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Various	NULL
constructs	NULL
with	NULL
the	NULL
indicated	NULL
mutations	NULL
were	NULL
transfected	NULL
into	NULL
NIH3T3	NULL
o	NULL
induction	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
earlier	NULL
finding	NULL
in	NULL
human	NULL
CPO	NULL
gene	NULL
promoter	NULL
activity	NULL
.	NULL
``	NULL

''	NULL
A	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
is	NULL
formed	NULL
at	NULL
CPRE	NULL
at	NULL
-49/-41	NULL
in	NULL
both	NULL
MEL	NULL
and	NULL
NIH3T3	NULL
cells	NULL
.	NULL

-	NULL
Our	NULL
results	NULL
demonstrated	NULL
that	NULL
CPRE	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
mouse	NULL
CPO	NULL
promoter	NULL
function	NULL
both	NULL
in	NULL
erythroid	NULL
and	NULL
in	NULL
nonerythroid	NULL
cells	NULL
.	NULL

To	NULL
identify	NULL
nuclear	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
this	NULL
element	NULL
,	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
CPRE	NULL
double-stranded	NULL
oligo-mer	NULL
.	NULL

When	NULL
the	NULL
radiolabeled	NULL
oligomer	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
MEL	NULL
cells	NULL
,	NULL
a	NULL
single	NULL
major	NULL
retarded	NULL
band	NULL
was	NULL
found	NULL
(	NULL
Fig	NULL
7	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

This	NULL
band	NULL
disappeared	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
125-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
unlabelled	NULL
CPRE	NULL
(	NULL
Fig	NULL
7	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
while	NULL
the	NULL
addition	NULL
of	NULL
CPREm	NULL
,	NULL
a	NULL
mutated	NULL
CPRE	NULL
oligomer	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
7	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

A	NULL
single	NULL
band	NULL
with	NULL
a	NULL
similar	NULL
gel	NULL
retardation	NULL
property	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
nuclear	NULL
extracts	NULL
from	NULL
NIH3T3	NULL
cells	NULL
were	NULL
used	NULL
(	NULL
Fig	NULL
7	NULL
lane	NULL
4	NULL
and	NULL
6	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
there	NULL
may	NULL
be	NULL
a	NULL
common	NULL
element	NULL
between	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cells	NULL
,	NULL
which	NULL
may	NULL
be	NULL
recognized	NULL
by	NULL
their	NULL
nuclear	NULL
proteins	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
DNA-protein	NULL
complex	NULL
at	NULL
this	NULL
site	NULL
was	NULL
Fig	NULL
5	NULL
.	NULL

Transient	NULL
mouse	NULL
CPO	NULL
gene	NULL
promoter	NULL
activity	NULL
in	NULL
MEL	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
_	NULL
,	NULL
,	NULL
,	NULL
,	NULL
th	NULL
--	NULL
-t-tH-t-m	NULL
--	NULL
I-B4H4-_	NULL
_	NULL
;	NULL
cells	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
means	NULL
of	NULL
50	NULL
100	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

unaffected	NULL
by	NULL
DMSO	NULL
treatment	NULL
of	NULL
MEL	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
however	NULL
,	NULL
suggesting	NULL
that	NULL
upregulation	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
by	NULL
DMSO	NULL
treatment	NULL
is	NULL
likely	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
transactivation	NULL
activity	NULL
of	NULL
CPRE-binding	NULL
protein	NULL
.	NULL

The	NULL
GATA	NULL
site	NULL
at	NULL
-59/-	NULL
54	NULL
is	NULL
recognized	NULL
by	NULL
GATA-1	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

-	NULL
Our	NULL
studies	NULL
show	NULL
that	NULL
GATA	NULL
site	NULL
at	NULL
-59/-54	NULL
is	NULL
also	NULL
important	NULL
for	NULL
the	NULL
CPO	NULL
promoter	NULL
function	NULL
(	NULL
Fig	NULL
6A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Because	NULL
GATA-1	NULL
is	NULL
known	NULL
to	NULL
be	NULL
abundantly	NULL
expressed	NULL
in	NULL
MEL	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
GATA-1	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
CPO	NULL
promoter	NULL
function	NULL
via	NULL
binding	NULL
to	NULL
GATA	NULL
site	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
showed	NULL
that	NULL
there	NULL
is	NULL
a	NULL
single	NULL
major	NULL
retardation	NULL
band	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
oligomer	NULL
corresponding	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
(	NULL
-59/-54	NULL
)	NULL
,	NULL
and	NULL
that	NULL
it	NULL
disappeared	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
250-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
oligomer	NULL
,	NULL
or	NULL
an	NULL
oligomer	NULL
containing	NULL
the	NULL
GATA	NULL
consensus	NULL
sequence	NULL
(	NULL
Fig	NULL
8	NULL
,	NULL
lane	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
addition	NULL
of	NULL
anti-GATA-1	NULL
antibody	NULL
entirely	NULL
super-shifted	NULL
this	NULL
band	NULL
(	NULL
Fig	NULL
8	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
indicate	NULL
that	NULL
GATA-1	NULL
specifically	NULL
binds	NULL
to	NULL
this	NULL
site	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
DNA-protein	NULL
complex	NULL
was	NULL
less	NULL
in	NULL
Relative	NULL
luciferase	NULL
activity	NULL
of	NULL
DMSO	NULL
.	NULL

MEL	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
series	NULL
of	NULL
5'-deletion	NULL
mutants	NULL
show	NULL
n	NULL
in	NULL
Fig	NULL
3	NULL
and	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
2	NULL
%	NULL
DMSO	NULL
for	NULL
20	NULL
hours	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
I	NULL
cara	NULL
as	NULL
ratios	NULL
to	NULL
the	NULL
luciferase	NULL
activity	NULL
I	NULL
cacee	NULL
of	NULL
pGL3-Basic	NULL
plasmid	NULL
in	NULL
the	NULL
cells	NULL
[	NULL
J	NULL
spike	NULL
without	NULL
DMSO	NULL
treatment	NULL
.	NULL

Data	NULL
are	NULL
means	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

ue	NULL
vous	NULL
Re	NULL
|	NULL
--	NULL
t	NULL
7	NULL
pood	NULL
p563DMSO	NULL
p207	NULL
p20T/DMSO	NULL
uuc	NULL
t	NULL
o	NULL
oe	NULL
54	NULL
r	NULL
pos	NULL
pb+/DMSO	NULL
“	NULL
LL	NULL
“	NULL
mi-z	NULL
!	NULL

3	NULL
E	NULL
meen	NULL
p2	NULL
p2DMSO	NULL
g	NULL
r	NULL
&	NULL
&	NULL
a	NULL
a	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REGULATION	NULL
OF	NULL
MOUSE	NULL
CPO	NULL
GENE	NULL
EXPRESSION	NULL
GATA	NULL
-	NULL
CPRE	NULL
-	NULL
SP1	NULL
like	NULL
(	NULL
-59/-54	NULL
)	NULL
(	NULL
-49/-41	NULL
)	NULL
(	NULL
-21/-12	NULL
)	NULL
A	NULL
P	NULL
.	NULL

<	NULL
)	NULL
LSJ	NULL
GS	NULL
Fig	NULL
6	NULL
.	NULL

Effect	NULL
of	NULL
disruption	NULL
of	NULL
individual	NULL
or	NULL
paired	NULL
cis-elements	NULL
on	NULL
luciferase	NULL
activities	NULL
.	NULL

(	NULL
A	NULL
)	NULL
MEL	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
various	NULL
constructs	NULL
with	NULL
the	NULL
indicated	NULL
mutations	NULL
and	NULL
incubated	NULL
for	NULL
20	NULL
hours	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DMSO	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
means	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
MEL	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
various	NULL
mutation	NULL
constructs	NULL
and	NULL
incubated	NULL
for	NULL
20	NULL
hours	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
DMSO	NULL
.	NULL

Fold	NULL
induction	NULL
is	NULL
expressed	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
luciferase	NULL
activities	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
indicated	NULL
constructs	NULL
in	NULL
the	NULL
figure	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
PGL3-Basic	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
means	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

C3	NULL
C-	NULL
(	NULL
Xy	NULL
-	NULL
CS	NULL
>	NULL
_	NULL
<	NULL
J	NULL
X	NULL
Las	NULL
)	NULL
E-s3	NULL
MEL	NULL
_	NULL
NIH3T3	NULL
CPRE	NULL
CPRE	NULL
self	NULL
=m	NULL
«	NULL
-m	NULL
COMP	NULL
.	NULL

self	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fig	NULL
7	NULL
.	NULL

Formation	NULL
of	NULL
a	NULL
DNA-protein	NULL
complex	NULL
with	NULL
CPRE	NULL
of	NULL
the	NULL
mouse	NULL
promoter	NULL
.	NULL

Five-microgram	NULL
aliquots	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
MEL	NULL
or	NULL
NIH3T3	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
end-labeled	NULL
oligomers	NULL
corresponding	NULL
to	NULL
CPRE	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
a	NULL
125-fold	NULL
(	NULL
M	NULL
EL	NULL
)	NULL
or	NULL
175-fold	NULL
(	NULL
NIH3T3	NULL
)	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
indicated	NULL
oligonucleo-tides	NULL
.	NULL

The	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
band	NULL
is	NULL
show	NULL
n	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

URS	NULL
&	NULL
C	NULL
f	NULL
p79GXm	NULL
p79Sm	NULL
p79SXm	NULL
p79GSm	NULL
3441	NULL
Relative	NULL
luciferase	NULL
activity	NULL
pT9	NULL
p79Gm	NULL
UC	NULL
p79Xm	NULL
T	NULL
f	NULL
I	NULL
0	NULL
50	NULL
100	NULL
Fold	NULL
Induction	NULL
p79GXm	NULL
1.4+0.2	NULL
p79	NULL
$	NULL
Xm	NULL
2.5+0.7	NULL
p79GSm	NULL
1.2+0.2	NULL
DMSO-treated	NULL
than	NULL
in	NULL
untreated	NULL
cells	NULL
(	NULL
Fig	NULL
8	NULL
,	NULL
lane	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

While	NULL
this	NULL
finding	NULL
seems	NULL
paradoxical	NULL
,	NULL
it	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
,	NULL
which	NULL
showed	NULL
that	NULL
GATA-1	NULL
mRNA	NULL
level	NULL
was	NULL
transiently	NULL
decreased	NULL
after	NULL
DMSO	NULL
treatment	NULL
,	NULL
but	NULL
recovered	NULL
with	NULL
time	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
GATA-1	NULL
may	NULL
become	NULL
transiently	NULL
either	NULL
active	NULL
,	NULL
or	NULL
an	NULL
interaction	NULL
between	NULL
GATA-1	NULL
and	NULL
other	NULL
nuclear	NULL
proteins	NULL
may	NULL
be	NULL
induced	NULL
by	NULL
DMSO	NULL
treatment	NULL
.	NULL

SP-1	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
SP-1-like	NULL
element	NULL
(	NULL
-21/-12	NULL
)	NULL
in	NULL
MEL	NULL
and	NULL
NIH3T3	NULL
cells	NULL
.	NULL

The	NULL
SP-l1-like	NULL
element	NULL
at	NULL
-21/-12	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
the	NULL
promoter	NULL
function	NULL
both	NULL
in	NULL
MEL	NULL
and	NULL
NIH3T3	NULL
cells	NULL
,	NULL
which	NULL
also	NULL
functions	NULL
synergistically	NULL
with	NULL
GATA-1	NULL
and	NULL
CPRE	NULL
binding	NULL
proteins	NULL
in	NULL
MEL	NULL
cells	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
9	NULL
,	NULL
when	NULL
a	NULL
nuclear	NULL
extract	NULL
prepared	NULL
from	NULL
MEL	NULL
cells	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
radiolabeled	NULL
oligomer	NULL
containing	NULL
the	NULL
SP-1-like	NULL
element	NULL
,	NULL
a	NULL
single	NULL
retarded	NULL
band	NULL
that	NULL
migrated	NULL
faster	NULL
than	NULL
that	NULL
with	NULL
SP-1	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
9	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

This	NULL
band	NULL
could	NULL
not	NULL
be	NULL
competed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
cold	NULL
oligomer	NULL
containing	NULL
SP-1	NULL
consensus	NULL
sequence	NULL
(	NULL
Fig	NULL
9	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

This	NULL
was	NULL
not	NULL
due	NULL
to	NULL
a	NULL
difference	NULL
in	NULL
the	NULL
affinity	NULL
of	NULL
SP-1	NULL
for	NULL
these	NULL
elements	NULL
,	NULL
as	NULL
the	NULL
band	NULL
representing	NULL
SP-1	NULL
was	NULL
not	NULL
suppressed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
excess	NULL
amount	NULL
of	NULL
the	NULL
cold	NULL
oligomer	NULL
containing	NULL
an	NULL
SP-l-like	NULL
element	NULL
(	NULL
Fig	NULL
9	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
anti-SP-1	NULL
antibody	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
band	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
,	NULL
which	NULL
forms	NULL
a	NULL
complex	NULL
with	NULL
SP-1	NULL
is	NULL
different	NULL
from	NULL
that	NULL
which	NULL
forms	NULL
a	NULL
complex	NULL
with	NULL
the	NULL
SP-l-like	NULL
element	NULL
.	NULL

A	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
was	NULL
also	NULL
formed	NULL
when	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
NIH3T3	NULL
cells	NULL
was	NULL
used	NULL
.	NULL

It	NULL
migrated	NULL
similarly	NULL
as	NULL
did	NULL
the	NULL
SP-1-DNA	NULL
complex	NULL
,	NULL
but	NULL
its	NULL
formation	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
excess	NULL
amount	NULL
of	NULL
the	NULL
cold	NULL
oligomer	NULL
corresponding	NULL
to	NULL
the	NULL
SP-1	NULL
consensus	NULL
sequence	NULL
(	NULL
Fig	NULL
9	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
,	NULL
as	NULL
in	NULL
the	NULL
case	NULL
with	NULL
MEL	NULL
cells	NULL
,	NULL
that	NULL
SP-1	NULL
also	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
this	NULL
element	NULL
in	NULL
NIH3T3	NULL
cells	NULL
.	NULL

It	NULL
should	NULL
also	NULL
be	NULL
noted	NULL
that	NULL
there	NULL
is	NULL
difference	NULL
in	NULL
the	NULL
migration	NULL
of	NULL
bands	NULL
between	NULL
MEL	NULL
and	NULL
NIH3T3	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
different	NULL
factors	NULL
may	NULL
bind	NULL
to	NULL
the	NULL
SP-1-like	NULL
element	NULL
in	NULL
each	NULL
type	NULL
of	NULL
cells	NULL
.	NULL

Alterna-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3442	NULL
MEL	NULL
DMSO	NULL
-	NULL
+	NULL
>	NULL
-	NULL
-	NULL
COMP	NULL
.	NULL

or	NULL
Ab	NULL
.	NULL

~	NULL
~	NULL
cote	NULL
&	NULL
n	NULL
``	NULL
``	NULL
self	NULL
CA	NULL
.CCC	NULL
Ap	NULL
,	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fig	NULL
8	NULL
.	NULL

Gel	NULL
mobility	NULL
shift/supershift	NULL
assay	NULL
of	NULL
MEL	NULL
cell	NULL
extracts	NULL
.	NULL

Five-microgram	NULL
aliquots	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
6	NULL
)	NULL
or	NULL
DMSO-treated	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
745A	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
end-labeled	NULL
oligomers	NULL
corresponding	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
(	NULL
-59/	NULL
-54	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
a	NULL
250-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
indicated	NULL
oligonucleotides	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
5	NULL
)	NULL
or	NULL
anti-GATA-1	NULL
antibody	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
arrowhead	NULL
indicates	NULL
the	NULL
complex	NULL
of	NULL
the	NULL
probe	NULL
and	NULL
GATA-1	NULL
,	NULL
and	NULL
the	NULL
arrow	NULL
represents	NULL
the	NULL
ternary	NULL
complex	NULL
of	NULL
the	NULL
probe	NULL
,	NULL
GATA-1	NULL
,	NULL
and	NULL
the	NULL
antibody	NULL
.	NULL

tively	NULL
,	NULL
the	NULL
same	NULL
factor	NULL
may	NULL
bind	NULL
with	NULL
different	NULL
affinities	NULL
in	NULL
a	NULL
different	NULL
cellular	NULL
environment	NULL
,	NULL
eg	NULL
,	NULL
proteolytic	NULL
modifications	NULL
in	NULL
MEL	NULL
cells	NULL
,	NULL
and	NULL
such	NULL
a	NULL
possibility	NULL
requires	NULL
further	NULL
in-vestigation	NULL
.	NULL

MEL	NULL
SP	NULL
1like	NULL
SP	NULL
tlike	NULL
TAKAHASHI	NULL
ET	NULL
AL	NULL
DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
regulatory	NULL
mechanism	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
expression	NULL
in	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cells	NULL
.	NULL

We	NULL
first	NULL
examined	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
and	NULL
identified	NULL
that	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
structure	NULL
is	NULL
highly	NULL
similar	NULL
to	NULL
the	NULL
human	NULL
CPO	NULL
gene	NULL
.	NULL

Namely	NULL
,	NULL
the	NULL
5'-upstream	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
contains	NULL
several	NULL
putative	NULL
cis-regulatory	NULL
elements	NULL
including	NULL
GATA	NULL
sites	NULL
,	NULL
CACCC	NULL
sites	NULL
,	NULL
and	NULL
SP-l-like	NULL
element	NULL
,	NULL
just	NULL
like	NULL
the	NULL
human	NULL
CPO	NULL
gene	NULL
.	NULL

The	NULL
spatial	NULL
arrangement	NULL
of	NULL
these	NULL
elements	NULL
is	NULL
also	NULL
similar	NULL
for	NULL
both	NULL
genes	NULL
,	NULL
'*	NULL
``	NULL
``	NULL
suggesting	NULL
that	NULL
CPO	NULL
gene	NULL
expression	NULL
may	NULL
be	NULL
regulated	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
between	NULL
mice	NULL
and	NULL
humans	NULL
.	NULL

By	NULL
examining	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
promoter	NULL
function	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
novel	NULL
regulatory	NULL
element	NULL
(	NULL
GGACTACAG	NULL
,	NULL
termed	NULL
CPRE	NULL
)	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
in	NULL
NIH3T3	NULL
cells	NULL
,	NULL
whereas	NULL
an	NULL
SP-1-like	NULL
element	NULL
at	NULL
-21/-12	NULL
was	NULL
also	NULL
required	NULL
for	NULL
maximal	NULL
promoter	NULL
activity	NULL
in	NULL
DMSO-induced	NULL
MEL	NULL
cells	NULL
(	NULL
Fig	NULL
4B	NULL
and	NULL
6A	NULL
)	NULL
.	NULL

Disruption	NULL
of	NULL
CPRE	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
NIH3T3	NULL
cells	NULL
,	NULL
while	NULL
it	NULL
decreased	NULL
the	NULL
promoter	NULL
activity	NULL
only	NULL
moderately	NULL
in	NULL
MEL	NULL
cells	NULL
(	NULL
Fig	NULL
4B	NULL
and	NULL
6A	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
different	NULL
role	NULL
of	NULL
CPRE	NULL
between	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cells	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
demonstrated	NULL
that	NULL
a	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
was	NULL
formed	NULL
at	NULL
CPRE	NULL
both	NULL
in	NULL
MEL	NULL
and	NULL
NIH3T3	NULL
cells	NULL
(	NULL
Fig	NULL
7	NULL
)	NULL
.	NULL

Our	NULL
search	NULL
in	NULL
the	NULL
GenBank	NULL
database	NULL
showed	NULL
that	NULL
CPRE	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
human	NULL
B-globin	NULL
gene	NULL
promoter	NULL
,	NULL
``	NULL
and	NULL
CPRE-related	NULL
sequences	NULL
are	NULL
also	NULL
found	NULL
in	NULL
genes	NULL
of	NULL
several	NULL
heme	NULL
biosynthetic	NULL
enzymes	NULL
,	NULL
such	NULL
as	NULL
uroporphyrinogen	NULL
decarboxylase	NULL
,	NULL
``	NULL
CPO	NULL
,	NULL
!	NULL

**°	NULL
rat	NULL
ALAS-N	NULL
,	NULL
*	NULL
``	NULL
and	NULL
in	NULL
the	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
mouse	NULL
PBGD	NULL
'	NULL
!	NULL

***	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

A	NULL
CPRE-related	NULL
sequence	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
human	NULL
ALAS-E	NULL
(	NULL
our	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unclear	NULL
at	NULL
present	NULL
whether	NULL
these	NULL
sequences	NULL
are	NULL
functional	NULL
or	NULL
not	NULL
,	NULL
but	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
CPRE-binding	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
may	NULL
contribute	NULL
to	NULL
heme	NULL
synthesis	NULL
by	NULL
exerting	NULL
its	NULL
effect	NULL
on	NULL
gene	NULL
expression	NULL
of	NULL
these	NULL
enzymes	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
interacts	NULL
with	NULL
this	NULL
element	NULL
may	NULL
therefore	NULL
be	NULL
important	NULL
for	NULL
better	NULL
understanding	NULL
of	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
heme	NULL
pathway	NULL
genes	NULL
.	NULL

NIHKH3T3	NULL
Fig	NULL
9	NULL
.	NULL

Formation	NULL
of	NULL
a	NULL
DNA-protein	NULL
complex	NULL
with	NULL
the	NULL
SP-1-like	NULL
element	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
PROBE	NULL
(	NULL
21/12	NULL
)	NULL
SP1	NULL
(	NULL
21412	NULL
)	NULL
SP1	NULL
promoter	NULL
.	NULL

Five-microgram	NULL
aliquots	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
SP1	NULL
SP1	NULL
745A	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
8	NULL
)	NULL
or	NULL
NIH3T3	NULL
COMP	NULL
.	NULL

_-	NULL
seSP1GA	NULL
-	NULL
ike	NULL
self	NULL
GA	NULL
w	NULL
H	NULL
‘	NULL
s	NULL
”	NULL
im	NULL
«	NULL
ical	NULL
1	NULL
2	NULL
3°	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
-	NULL
self	NULL
SP1GA	NULL
_-	NULL
-like	NULL
self	NULL
GA	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
16	NULL
)	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
end-labeled	NULL
oligomers	NULL
corresponding	NULL
to	NULL
the	NULL
SP-1-like	NULL
element	NULL
(	NULL
-21/-11	NULL
)	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
,	NULL
9	NULL
to	NULL
12	NULL
)	NULL
or	NULL
the	NULL
SP-1	NULL
consensus	NULL
sequence	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
,	NULL
13	NULL
to	NULL
16	NULL
)	NULL
.	NULL

Competition	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
250-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
SP-1-like	NULL
element	NULL
(	NULL
-21/-11	NULL
)	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
6	NULL
,	NULL
10	NULL
,	NULL
14	NULL
)	NULL
,	NULL
SP-1	NULL
consensus	NULL
sequence	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
11	NULL
,	NULL
15	NULL
)	NULL
,	NULL
and	NULL
GATA	NULL
consensus	NULL
sequence	NULL
from	NULL
the	NULL
human	NULL
ALAS-E	NULL
promoter	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
and	NULL
the	NULL
arrowheads	NULL
indicate	NULL
the	NULL
complexes	NULL
of	NULL
the	NULL
probe	NULL
and	NULL
nuclear	NULL
proteins	NULL
.	NULL

‘	NULL
Y	NULL
.	NULL

--	NULL
aSP	NULL
1	NULL
sms	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REGULATION	NULL
OF	NULL
MOUSE	NULL
CPO	NULL
GENE	NULL
EXPRESSION	NULL
Our	NULL
previous	NULL
studies	NULL
showed	NULL
that	NULL
an	NULL
SP-1	NULL
site	NULL
adjacent	NULL
to	NULL
the	NULL
GATA	NULL
sequence	NULL
in	NULL
the	NULL
human	NULL
CPO	NULL
gene	NULL
contributes	NULL
to	NULL
basic	NULL
gene	NULL
expression	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
Therefore	NULL
,	NULL
we	NULL
suspected	NULL
that	NULL
an	NULL
SP-1-like	NULL
element	NULL
at	NULL
-21/-12	NULL
in	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
promoter	NULL
function	NULL
.	NULL

Indeed	NULL
,	NULL
its	NULL
disruption	NULL
resulted	NULL
in	NULL
a	NULL
moderate	NULL
decrease	NULL
in	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
NIH3T3	NULL
cells	NULL
,	NULL
indicating	NULL
its	NULL
contribution	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

In	NULL
MEL	NULL
cells	NULL
,	NULL
the	NULL
SP-1-like	NULL
element	NULL
alone	NULL
,	NULL
however	NULL
,	NULL
demonstrated	NULL
only	NULL
a	NULL
very	NULL
low	NULL
activity	NULL
,	NULL
but	NULL
its	NULL
combination	NULL
with	NULL
CPRE	NULL
or	NULL
GATA	NULL
site	NULL
(	NULL
-59/-54	NULL
)	NULL
markedly	NULL
enhanced	NULL
the	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
demonstrated	NULL
that	NULL
this	NULL
element	NULL
may	NULL
be	NULL
recognized	NULL
by	NULL
different	NULL
nuclear	NULL
factors	NULL
between	NULL
MEL	NULL
and	NULL
NIH3T3	NULL
cells	NULL
(	NULL
Fig	NULL
9	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
transcriptional	NULL
regulation	NULL
by	NULL
SP-l-like	NULL
element	NULL
may	NULL
be	NULL
different	NULL
between	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cells	NULL
.	NULL

A	NULL
similar	NULL
GC-rich	NULL
element	NULL
also	NULL
exists	NULL
in	NULL
the	NULL
proximal	NULL
promoter	NULL
region	NULL
of	NULL
human	NULL
ferrochelatase	NULL
gene	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
there	NULL
may	NULL
be	NULL
a	NULL
role	NULL
of	NULL
this	NULL
element	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
other	NULL
heme	NULL
biosynthetic	NULL
enzymes	NULL
,	NULL
and	NULL
this	NULL
question	NULL
should	NULL
be	NULL
clarified	NULL
.	NULL

The	NULL
GATA	NULL
site	NULL
at	NULL
-59/-54	NULL
was	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
GATA-1	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
findings	NULL
for	NULL
its	NULL
role	NULL
in	NULL
human	NULL
CPO	NULL
gene	NULL
expression	NULL
(	NULL
Fig	NULL
8	NULL
)	NULL
.	NULL
``	NULL

''	NULL
Because	NULL
GATA	NULL
factors	NULL
are	NULL
key	NULL
contributors	NULL
to	NULL
the	NULL
differentiation	NULL
process	NULL
of	NULL
hematopoietic	NULL
cells	NULL
``	NULL
?	NULL
``	NULL

and	NULL
because	NULL
GATA	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
widely	NULL
found	NULL
in	NULL
the	NULL
gene	NULL
promoter	NULL
of	NULL
several	NULL
heme	NULL
synthetic	NULL
pathway	NULL
enzymes	NULL
,	NULL
``	NULL
GATA-1	NULL
may	NULL
also	NULL
be	NULL
essential	NULL
for	NULL
upregulation	NULL
of	NULL
the	NULL
CPO	NULL
gene	NULL
during	NULL
erythroid	NULL
differentiation	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
the	NULL
GATA	NULL
site	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
CPRE	NULL
,	NULL
showed	NULL
only	NULL
a	NULL
low	NULL
reporter	NULL
activity	NULL
,	NULL
while	NULL
together	NULL
with	NULL
the	NULL
SP-1-like	NULL
element	NULL
,	NULL
it	NULL
markedly	NULL
stimulated	NULL
the	NULL
activity	NULL
in	NULL
MEL	NULL
cells	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

Synergistic	NULL
effects	NULL
of	NULL
various	NULL
combinations	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
GATA-1	NULL
,	NULL
on	NULL
TATA-less	NULL
promoters	NULL
have	NULL
been	NULL
reported	NULL
.	NULL

``	NULL
>	NULL
``	NULL
Our	NULL
results	NULL
also	NULL
suggest	NULL
that	NULL
interaction	NULL
between	NULL
GATA-1	NULL
and	NULL
SP-1-like	NULL
element-binding	NULL
proteins	NULL
,	NULL
as	NULL
well	NULL
as	NULL
CPRE	NULL
and	NULL
SP-l-like	NULL
element-binding	NULL
proteins	NULL
may	NULL
be	NULL
important	NULL
for	NULL
CPO	NULL
gene	NULL
expression	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

GATA-1	NULL
significantly	NULL
contributes	NULL
to	NULL
the	NULL
DMSO-induced	NULL
promoter	NULL
activity	NULL
in	NULL
MEL	NULL
cells	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
GATA-1-DNA	NULL
complex	NULL
formed	NULL
at	NULL
the	NULL
-59/-54	NULL
GATA	NULL
site	NULL
was	NULL
slightly	NULL
decreased	NULL
by	NULL
DMSO	NULL
treatment	NULL
of	NULL
MEL	NULL
cells	NULL
(	NULL
Fig	NULL
8	NULL
)	NULL
.	NULL

DMSO	NULL
treatment	NULL
also	NULL
did	NULL
not	NULL
increase	NULL
the	NULL
formation	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
at	NULL
CPRE	NULL
and	NULL
SP-l-like	NULL
element	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
GATA-1-mediated	NULL
increase	NULL
in	NULL
Table	NULL
2	NULL
.	NULL

CPRE-Like	NULL
Sequences	NULL
Found	NULL
in	NULL
the	NULL
Other	NULL
Gene	NULL
Promoter	NULL
Regions	NULL
CPRE	NULL
Related	NULL
Sequences	NULL
Localization*	NULL
Mouse	NULL
CPO	NULL
gacg	NULL
GGACTACAG	NULL
ttce	NULL
-49	NULL
to	NULL
-41	NULL
Human	NULL
ALAS-E	NULL
tctc	NULL
TGACTATAG	NULL
atct	NULL
-	NULL
-286	NULL
to	NULL
-279	NULL
Rat	NULL
ALAS-N	NULL
ggtg	NULL
TEACTACAT	NULL
gaga	NULL
-	NULL
-689	NULL
to	NULL
-681	NULL
Mouse	NULL
PBGD	NULL
(	NULL
ery	NULL
throid	NULL
promoter	NULL
)	NULL
ttte	NULL
GGACAACAG	NULL
ggag	NULL
-	NULL
-744	NULL
to	NULL
-736	NULL
Mouse	NULL
PBGD	NULL
(	NULL
non-	NULL
C	NULL
erythroid	NULL
pro	NULL
moter	NULL
)	NULL
cagt	NULL
GGACTTGAG	NULL
cgaa	NULL
-70	NULL
to	NULL
-62	NULL
Human	NULL
UROD	NULL
gate	NULL
ccactccas	NULL
cgac	NULL
-	NULL
-137	NULL
to	NULL
-129	NULL
Human	NULL
CPO	NULL
cas	NULL
-97	NULL
to	NULL
-89	NULL
atce	NULL
GGACTACAG	NULL
ctce	NULL
*From	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

3443	NULL
Erythroid	NULL
cells	NULL
binding	NULL
protein	NULL
Non-erythroid	NULL
cells	NULL
binding	NULL
protein	NULL
Fig	NULL
10	NULL
.	NULL

-	NULL
Model	NULL
of	NULL
the	NULL
differential	NULL
regulation	NULL
of	NULL
the	NULL
mouse	NULL
CPO	NULL
gene	NULL
promoter	NULL
function	NULL
in	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cells	NULL
.	NULL

transactivation	NULL
and	NULL
a	NULL
decrease	NULL
in	NULL
DNA	NULL
binding	NULL
in	NULL
DMSO-treated	NULL
MEL	NULL
cells	NULL
may	NULL
seem	NULL
paradoxical	NULL
.	NULL

However	NULL
,	NULL
our	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
an	NULL
earlier	NULL
report	NULL
,	NULL
which	NULL
showed	NULL
that	NULL
MEL	NULL
cells	NULL
contain	NULL
two	NULL
distinct	NULL
GATA-binding	NULL
proteins	NULL
that	NULL
have	NULL
different	NULL
patterns	NULL
of	NULL
expression	NULL
during	NULL
erythroid	NULL
differentiation	NULL
,	NULL
and	NULL
that	NULL
GATA-1	NULL
mRNA	NULL
levels	NULL
decreased	NULL
transiently	NULL
during	NULL
DMSO-induced	NULL
differentiation	NULL
.	NULL
``	NULL

One	NULL
possible	NULL
explanation	NULL
may	NULL
be	NULL
that	NULL
GATA-1	NULL
may	NULL
become	NULL
an	NULL
active	NULL
form	NULL
by	NULL
certain	NULL
modification	NULL
such	NULL
as	NULL
phosphorylation	NULL
during	NULL
erythroid	NULL
differen-tiation	NULL
.	NULL
``	NULL

''	NULL
Alternatively	NULL
,	NULL
DMSO	NULL
treatment	NULL
may	NULL
induce	NULL
interaction	NULL
among	NULL
transcription	NULL
factors	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
function	NULL
.	NULL

To	NULL
account	NULL
for	NULL
tissue-specific	NULL
regulation	NULL
,	NULL
we	NULL
provide	NULL
a	NULL
hypothetical	NULL
scheme	NULL
for	NULL
differential	NULL
CPO	NULL
regulation	NULL
between	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cells	NULL
(	NULL
Fig	NULL
10	NULL
)	NULL
.	NULL

Namely	NULL
,	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
binding	NULL
proteins	NULL
to	NULL
the	NULL
SP-l-like	NULL
element	NULL
,	NULL
CPRE	NULL
and	NULL
GATA-1	NULL
,	NULL
cooperatively	NULL
function	NULL
in	NULL
CPO	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
nonerythroid	NULL
cells	NULL
,	NULL
CPRE-binding	NULL
protein	NULL
by	NULL
itself	NULL
plays	NULL
a	NULL
principal	NULL
role	NULL
in	NULL
basic	NULL
expression	NULL
,	NULL
while	NULL
GATA-1	NULL
plays	NULL
little	NULL
role	NULL
and	NULL
the	NULL
SP-1-like	NULL
element	NULL
may	NULL
exert	NULL
only	NULL
a	NULL
moderate	NULL
activity	NULL
.	NULL

The	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
CPO	NULL
gene	NULL
promoter	NULL
function	NULL
may	NULL
also	NULL
be	NULL
influenced	NULL
by	NULL
differences	NULL
in	NULL
the	NULL
affinity	NULL
of	NULL
tissue-specific	NULL
factors	NULL
to	NULL
the	NULL
SP-1-like	NULL
element	NULL
,	NULL
Factor	NULL
X	NULL
and	NULL
Y	NULL
in	NULL
MEL	NULL
and	NULL
NIH3T3	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

While	NULL
the	NULL
exact	NULL
nature	NULL
of	NULL
the	NULL
regulatory	NULL
mechanism	NULL
of	NULL
CPO	NULL
gene	NULL
expression	NULL
is	NULL
yet	NULL
to	NULL
be	NULL
clarified	NULL
,	NULL
this	NULL
model	NULL
should	NULL
serve	NULL
as	NULL
a	NULL
useful	NULL
hypothesis	NULL
for	NULL
evaluation	NULL
for	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
heme	NULL
biosynthetic	NULL
enzymes	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Drs	NULL
H.	NULL
Motohashi	NULL
,	NULL
N.	NULL
Minegishi	NULL
,	NULL
K.	NULL
Furuyama	NULL
,	NULL
S.	NULL
Suzuki	NULL
,	NULL
and	NULL
H.	NULL
Ohtsu	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3444	NULL
REFERENCES	NULL
1	NULL
.	NULL

Sassa	NULL
S	NULL
,	NULL
Nagai	NULL
T	NULL
:	NULL
The	NULL
role	NULL
of	NULL
heme	NULL
in	NULL
gene	NULL
expression	NULL
.	NULL

Int	NULL
J	NULL
Hematology	NULL
63:167	NULL
,	NULL
1996	NULL
2	NULL
.	NULL

Fujita	NULL
H	NULL
,	NULL
Yamamoto	NULL
M	NULL
,	NULL
Yamagami	NULL
T	NULL
,	NULL
Hayashi	NULL
N	NULL
,	NULL
Bishop	NULL
TR	NULL
,	NULL
DeVernuil	NULL
H	NULL
,	NULL
Yoshinaga	NULL
T	NULL
,	NULL
Shibahara	NULL
S	NULL
,	NULL
Morimoto	NULL
R	NULL
,	NULL
Sassa	NULL
S	NULL
:	NULL
Sequential	NULL
activation	NULL
of	NULL
genes	NULL
for	NULL
heme	NULL
pathway	NULL
enzymes	NULL
during	NULL
erythroid	NULL
differentiation	NULL
of	NULL
mouse	NULL
Friend	NULL
virus-transformed	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Acta	NULL
1093:311	NULL
,	NULL
1991	NULL
3	NULL
.	NULL

Sassa	NULL
S	NULL
:	NULL
Sequential	NULL
induction	NULL
of	NULL
heme	NULL
pathway	NULL
enzymes	NULL
during	NULL
erythroid	NULL
differentiation	NULL
of	NULL
mouse	NULL
Friend	NULL
leukemia	NULL
virus-infected	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
143:305	NULL
,	NULL
1976	NULL
4	NULL
.	NULL

Fujita	NULL
H	NULL
,	NULL
Yamamoto	NULL
M	NULL
,	NULL
Yamagami	NULL
T	NULL
,	NULL
Hayashi	NULL
N	NULL
,	NULL
Sassa	NULL
S	NULL
:	NULL
Erythroleukemia	NULL
differentiation	NULL
.	NULL

Distinctive	NULL
responses	NULL
of	NULL
the	NULL
erythroid-specific	NULL
and	NULL
the	NULL
nonspecific	NULL
delta-aminolevulinate	NULL
synthase	NULL
mRNA	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:17494	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Nagai	NULL
T	NULL
,	NULL
Harigae	NULL
H	NULL
,	NULL
Furuyama	NULL
K	NULL
,	NULL
Munakata	NULL
H	NULL
,	NULL
Hayashi	NULL
N	NULL
,	NULL
Endo	NULL
K	NULL
,	NULL
Sassa	NULL
S	NULL
,	NULL
Yamamoto	NULL
M	NULL
:	NULL
5-Aminolevulinate	NULL
synthase	NULL
expression	NULL
and	NULL
hemoglobin	NULL
synthesis	NULL
in	NULL
a	NULL
human	NULL
myelogenous	NULL
leukemia	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Biochem	NULL
121:487	NULL
,	NULL
1997	NULL
6	NULL
.	NULL

Watanabe	NULL
N	NULL
,	NULL
Hayashi	NULL
N	NULL
,	NULL
Kikuchi	NULL
G	NULL
:	NULL
Delta-aminolevulinate	NULL
synthase	NULL
isozymes	NULL
in	NULL
the	NULL
liver	NULL
and	NULL
erythroid	NULL
cells	NULL
of	NULL
chicken	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
113:377	NULL
,	NULL
1983	NULL
7	NULL
.	NULL

Yamamoto	NULL
M	NULL
,	NULL
Yew	NULL
NS	NULL
,	NULL
Federspiel	NULL
M	NULL
,	NULL
Dodgson	NULL
JB	NULL
,	NULL
Hayashi	NULL
N	NULL
,	NULL
Engel	NULL
JD	NULL
:	NULL
Isolation	NULL
of	NULL
recombinant	NULL
cDNAs	NULL
encoding	NULL
chicken	NULL
erythroid	NULL
delta-aminolevulinate	NULL
synthase	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
82:3702	NULL
,	NULL
1985	NULL
8	NULL
.	NULL

Bishop	NULL
TR	NULL
,	NULL
Miller	NULL
MW	NULL
,	NULL
Beall	NULL
J	NULL
,	NULL
Zon	NULL
LI	NULL
,	NULL
Dierks	NULL
P	NULL
:	NULL
Genetic	NULL
regulation	NULL
of	NULL
delta-aminolevulinate	NULL
dehydratase	NULL
during	NULL
erythropoiesis	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
24:2511	NULL
,	NULL
1996	NULL
9	NULL
.	NULL

Chretien	NULL
S	NULL
,	NULL
Dubart	NULL
A	NULL
,	NULL
Beaupain	NULL
D	NULL
,	NULL
Raich	NULL
N	NULL
,	NULL
Grandchamp	NULL
B	NULL
,	NULL
Rosa	NULL
J	NULL
,	NULL
Goossens	NULL
M	NULL
,	NULL
Romeo	NULL
PH	NULL
:	NULL
Alternative	NULL
transcription	NULL
and	NULL
splicing	NULL
of	NULL
the	NULL
human	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
result	NULL
either	NULL
in	NULL
tissue-specific	NULL
or	NULL
in	NULL
housekeeping	NULL
expression	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:6	NULL
,	NULL
1988	NULL
10	NULL
.	NULL

Beaumont	NULL
C	NULL
,	NULL
Porcher	NULL
C	NULL
,	NULL
Picat	NULL
C	NULL
,	NULL
Nordmann	NULL
Y	NULL
,	NULL
Grandchamp	NULL
B	NULL
:	NULL
The	NULL
mouse	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
.	NULL

Structural	NULL
organization	NULL
,	NULL
sequence	NULL
,	NULL
and	NULL
transcriptional	NULL
analysis	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
264:14829	NULL
,	NULL
1989	NULL
11	NULL
.	NULL

Yoshinaga	NULL
T	NULL
,	NULL
Sano	NULL
S	NULL
:	NULL
Coproporphyrinogen	NULL
oxidase	NULL
.	NULL

I.	NULL
Purification	NULL
,	NULL
properties	NULL
,	NULL
and	NULL
activation	NULL
by	NULL
phospholipids	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
255	NULL
:	NULL
4722	NULL
,	NULL
1980	NULL
12	NULL
.	NULL

Conder	NULL
LH	NULL
,	NULL
Woodard	NULL
SI	NULL
,	NULL
Dailey	NULL
HA	NULL
:	NULL
Multiple	NULL
mechanisms	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
haem	NULL
synthesis	NULL
during	NULL
erythroid	NULL
cell	NULL
differentiation	NULL
.	NULL

Possible	NULL
role	NULL
for	NULL
coproporphyrinogen	NULL
oxidase	NULL
.	NULL

Biochem	NULL
J	NULL
275:321	NULL
,	NULL
1991	NULL
13	NULL
.	NULL

Nagai	NULL
M	NULL
,	NULL
Nagai	NULL
T	NULL
,	NULL
Yamamoto	NULL
M	NULL
,	NULL
Goto	NULL
K	NULL
,	NULL
Bishop	NULL
TR	NULL
,	NULL
Hayashi	NULL
N	NULL
,	NULL
Kondo	NULL
H	NULL
,	NULL
Seyama	NULL
Y	NULL
,	NULL
Kano	NULL
K	NULL
,	NULL
Fujita	NULL
H	NULL
,	NULL
Sassa	NULL
S	NULL
:	NULL
Novel	NULL
regulation	NULL
of	NULL
delta-aminolevulinate	NULL
synthase	NULL
in	NULL
the	NULL
rat	NULL
harderian	NULL
gland	NULL
.	NULL

Biochem	NULL
Pharmacol	NULL
53:643	NULL
,	NULL
1997	NULL
14	NULL
.	NULL

Delfau-Larue	NULL
MH	NULL
,	NULL
Martasek	NULL
P	NULL
,	NULL
Grandchamp	NULL
B	NULL
:	NULL
Coproporphyrinogen	NULL
oxidase	NULL
:	NULL
Gene	NULL
organization	NULL
and	NULL
description	NULL
of	NULL
a	NULL
mutation	NULL
leading	NULL
to	NULL
exon	NULL
6	NULL
skipping	NULL
.	NULL

Hum	NULL
Mol	NULL
Genet	NULL
3:1325	NULL
,	NULL
1994	NULL
15	NULL
.	NULL

Kohno	NULL
H	NULL
,	NULL
Furukawa	NULL
T	NULL
,	NULL
Yoshinaga	NULL
T	NULL
,	NULL
Tokunaga	NULL
R	NULL
,	NULL
Taketani	NULL
S	NULL
:	NULL
Coproporphyrinogen	NULL
oxidase	NULL
.	NULL

Purification	NULL
,	NULL
molecular	NULL
cloning	NULL
,	NULL
and	NULL
induction	NULL
of	NULL
mRNA	NULL
during	NULL
erythroid	NULL
differentiation	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:21359	NULL
,	NULL
1993	NULL
16	NULL
.	NULL

Taketani	NULL
S	NULL
,	NULL
Inazawa	NULL
J	NULL
,	NULL
Abe	NULL
T	NULL
,	NULL
Furukawa	NULL
T	NULL
,	NULL
Kohno	NULL
H	NULL
,	NULL
Tokunaga	NULL
R	NULL
,	NULL
Nishimura	NULL
K	NULL
,	NULL
Inokuchi	NULL
H	NULL
:	NULL
The	NULL
human	NULL
protoporphyrinogen	NULL
oxidase	NULL
gene	NULL
(	NULL
PPOX	NULL
)	NULL
:	NULL
Organization	NULL
and	NULL
location	NULL
to	NULL
chromosome	NULL
1	NULL
.	NULL

Genomics	NULL
29:698	NULL
,	NULL
1995	NULL
17	NULL
.	NULL

Onodera	NULL
K	NULL
,	NULL
Yomogida	NULL
K	NULL
,	NULL
Suwabe	NULL
N	NULL
,	NULL
Takahashi	NULL
S	NULL
,	NULL
Muraosa	NULL
Y	NULL
,	NULL
Hayashi	NULL
N	NULL
,	NULL
Ito	NULL
E	NULL
,	NULL
Gu	NULL
L	NULL
,	NULL
Rassoulzadegan	NULL
M	NULL
,	NULL
Engel	NULL
J	NULL
,	NULL
Yamamoto	NULL
M	NULL
:	NULL
Conserved	NULL
structure	NULL
,	NULL
regulatory	NULL
elements	NULL
,	NULL
and	NULL
transcriptional	NULL
regulation	NULL
from	NULL
the	NULL
GATA-1	NULL
gene	NULL
testis	NULL
promoter	NULL
.	NULL

J	NULL
Biochem	NULL
121:251	NULL
,	NULL
1997	NULL
18	NULL
.	NULL

Nagai	NULL
T	NULL
,	NULL
Igarashi	NULL
K	NULL
,	NULL
Akasaka	NULL
J	NULL
,	NULL
Furuyama	NULL
K	NULL
,	NULL
Fujita	NULL
H	NULL
,	NULL
Hayashi	NULL
TAKAHASHI	NULL
ET	NULL
AL	NULL
N	NULL
,	NULL
Yamamoto	NULL
M	NULL
,	NULL
Sassa	NULL
S	NULL
:	NULL
Regulation	NULL
of	NULL
NF-E2	NULL
activity	NULL
in	NULL
erythroleukemia	NULL
cell	NULL
differentiation	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
273:5358	NULL
,	NULL
1998	NULL
19	NULL
.	NULL

Lassar	NULL
AB	NULL
,	NULL
Davis	NULL
RL	NULL
,	NULL
Wright	NULL
WE	NULL
,	NULL
Kadesch	NULL
T	NULL
,	NULL
Murre	NULL
C	NULL
,	NULL
Voronova	NULL
A	NULL
,	NULL
Baltimore	NULL
D	NULL
,	NULL
Weintraub	NULL
H	NULL
;	NULL
:	NULL
Functional	NULL
activity	NULL
of	NULL
myo-genic	NULL
HLH	NULL
proteins	NULL
requires	NULL
hetero-oligomerization	NULL
with	NULL
E12/E47-like	NULL
proteins	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
66:305	NULL
,	NULL
1991	NULL
20	NULL
.	NULL

Tanabe	NULL
A	NULL
,	NULL
Furukawa	NULL
T	NULL
,	NULL
Ogawa	NULL
Y	NULL
,	NULL
Yamamoto	NULL
M	NULL
,	NULL
Hayashi	NULL
N	NULL
,	NULL
Tokunaga	NULL
R	NULL
,	NULL
Taketani	NULL
S	NULL
:	NULL
Involvement	NULL
of	NULL
the	NULL
transcriptional	NULL
factor	NULL
GATA-1	NULL
in	NULL
regulation	NULL
of	NULL
expression	NULL
of	NULL
coproporphyrinogen	NULL
oxidase	NULL
in	NULL
mouse	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
233:729	NULL
,	NULL
1997	NULL
21	NULL
.	NULL

Orkin	NULL
SH	NULL
:	NULL
GATA-binding	NULL
transcription	NULL
factors	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Blood	NULL
80:575	NULL
,	NULL
1992	NULL
22	NULL
.	NULL

Weiss	NULL
MJ	NULL
,	NULL
Keller	NULL
G	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Novel	NULL
insights	NULL
into	NULL
erythroid	NULL
development	NULL
revealed	NULL
through	NULL
in	NULL
vitro	NULL
differentiation	NULL
of	NULL
GATA-1	NULL
embryonic	NULL
stem	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
8:1184	NULL
,	NULL
1994	NULL
23	NULL
.	NULL

Ness	NULL
SA	NULL
,	NULL
Engel	NULL
JD	NULL
:	NULL
Vintage	NULL
reds	NULL
and	NULL
whites	NULL
:	NULL
Combinatorial	NULL
transcription	NULL
factor	NULL
utilization	NULL
in	NULL
hematopoietic	NULL
differentiation	NULL
.	NULL

Curr	NULL
Opin	NULL
Genet	NULL
Dev	NULL
4:718	NULL
,	NULL
1994	NULL
24	NULL
.	NULL

Avissar	NULL
YJ	NULL
,	NULL
Nadler	NULL
KD	NULL
:	NULL
Stimulation	NULL
of	NULL
tetrapyrrole	NULL
formation	NULL
in	NULL
Rhizobium	NULL
japonicum	NULL
by	NULL
restricted	NULL
aeration	NULL
.	NULL

J	NULL
Bacteriol	NULL
135:782	NULL
,	NULL
1978	NULL
25	NULL
.	NULL

Yu	NULL
J	NULL
,	NULL
Bock	NULL
JH	NULL
,	NULL
Slightom	NULL
JL	NULL
,	NULL
Villeponteau	NULL
B	NULL
:	NULL
A	NULL
5	NULL
'	NULL
B-globin	NULL
matrix-attachment	NULL
region	NULL
and	NULL
the	NULL
polyoma	NULL
enhancer	NULL
together	NULL
confer	NULL
position-independent	NULL
transcription	NULL
.	NULL

Gene	NULL
139:139	NULL
,	NULL
1994	NULL
26	NULL
.	NULL

Moran-Jimenez	NULL
MJ	NULL
,	NULL
Ged	NULL
C	NULL
,	NULL
Romana	NULL
M	NULL
,	NULL
Enriquez	NULL
De	NULL
Salamanca	NULL
R	NULL
,	NULL
Taieb	NULL
A	NULL
,	NULL
Topi	NULL
G	NULL
,	NULL
D'Alessandro	NULL
L	NULL
,	NULL
de	NULL
Verneuil	NULL
H	NULL
;	NULL
Uroporphyrinogen	NULL
decarboxylase	NULL
:	NULL
Complete	NULL
human	NULL
gene	NULL
sequence	NULL
and	NULL
molecular	NULL
study	NULL
of	NULL
three	NULL
families	NULL
with	NULL
hepatoerythropoietic	NULL
porphyria	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
58:712	NULL
,	NULL
1996	NULL
27	NULL
.	NULL

Yomogida	NULL
K	NULL
,	NULL
Yamamoto	NULL
M	NULL
,	NULL
Yamagami	NULL
T	NULL
,	NULL
Fujita	NULL
H	NULL
,	NULL
Hayashi	NULL
N	NULL
:	NULL
Structure	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
rat	NULL
nonspecific	NULL
form	NULL
delta-aminolevulinate	NULL
synthase	NULL
.	NULL

J	NULL
Biochem	NULL
113:364	NULL
,	NULL
1993	NULL
28	NULL
.	NULL

Porcher	NULL
C	NULL
,	NULL
Pitiot	NULL
G	NULL
,	NULL
Plumb	NULL
M	NULL
,	NULL
Lowe	NULL
S	NULL
,	NULL
de	NULL
Verneuil	NULL
H	NULL
,	NULL
Grandchamp	NULL
B	NULL
:	NULL
Characterization	NULL
of	NULL
hypersensitive	NULL
sites	NULL
,	NULL
protein-binding	NULL
motifs	NULL
,	NULL
and	NULL
regulatory	NULL
elements	NULL
in	NULL
both	NULL
promoters	NULL
of	NULL
the	NULL
mouse	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:10562	NULL
,	NULL
1991	NULL
29	NULL
.	NULL

Taketani	NULL
S	NULL
,	NULL
Inazawa	NULL
J	NULL
,	NULL
Nakahashi	NULL
Y	NULL
,	NULL
Abe	NULL
T	NULL
,	NULL
Tokunaga	NULL
R	NULL
:	NULL
Structure	NULL
of	NULL
the	NULL
human	NULL
ferrochelatase	NULL
gene	NULL
.	NULL

Exon/intron	NULL
gene	NULL
organization	NULL
and	NULL
location	NULL
of	NULL
the	NULL
gene	NULL
to	NULL
chromosome	NULL
18	NULL
.	NULL

Eur	NULL
J	NULL
Biochem	NULL
205:217	NULL
,	NULL
1992	NULL
30	NULL
.	NULL

Nagai	NULL
T	NULL
,	NULL
Harigae	NULL
H	NULL
,	NULL
Ishihara	NULL
H	NULL
,	NULL
Motohashi	NULL
H	NULL
,	NULL
Minegishi	NULL
N	NULL
,	NULL
Tsuchiya	NULL
S	NULL
,	NULL
Hayashi	NULL
N	NULL
,	NULL
Gu	NULL
L	NULL
,	NULL
Andres	NULL
B	NULL
,	NULL
Engel	NULL
JD	NULL
,	NULL
Takahashi	NULL
S	NULL
,	NULL
Taketani	NULL
S	NULL
,	NULL
Akasaka	NULL
J	NULL
,	NULL
Kobayashi	NULL
A	NULL
,	NULL
Hayashi	NULL
N	NULL
,	NULL
Yamamoto	NULL
M	NULL
,	NULL
Nagai	NULL
T	NULL
:	NULL
Transcription	NULL
factor	NULL
GATA-2	NULL
is	NULL
expressed	NULL
in	NULL
erythroid	NULL
,	NULL
early	NULL
myeloid	NULL
,	NULL
and	NULL
CD34+	NULL
human	NULL
leukemia-derived	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
84:1074	NULL
,	NULL
1994	NULL
31	NULL
.	NULL

Ponka	NULL
P	NULL
:	NULL
Tissue-specific	NULL
regulation	NULL
of	NULL
iron	NULL
metabolism	NULL
and	NULL
heme	NULL
synthesis	NULL
:	NULL
Distinct	NULL
control	NULL
mechanisms	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Blood	NULL
89:1	NULL
,	NULL
1997	NULL
32	NULL
.	NULL

Wadman	NULL
IA	NULL
,	NULL
Osada	NULL
H	NULL
,	NULL
Grutz	NULL
GG	NULL
,	NULL
Agulnick	NULL
AD	NULL
,	NULL
Westphal	NULL
H	NULL
,	NULL
Forster	NULL
A	NULL
,	NULL
Rabbitts	NULL
TH	NULL
:	NULL
The	NULL
LIM-only	NULL
protein	NULL
Lmo2	NULL
is	NULL
a	NULL
bridging	NULL
molecule	NULL
assembling	NULL
an	NULL
erythroid	NULL
,	NULL
DNA-binding	NULL
complex	NULL
which	NULL
includes	NULL
the	NULL
TAL1	NULL
,	NULL
E47	NULL
,	NULL
GATA-1	NULL
and	NULL
Ldbl/NLI	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
16:3145	NULL
,	NULL
1997	NULL
33	NULL
.	NULL

Gregory	NULL
RC	NULL
,	NULL
Taxman	NULL
DJ	NULL
,	NULL
Seshasayee	NULL
D	NULL
,	NULL
Kensinger	NULL
MH	NULL
,	NULL
Bieker	NULL
JJ	NULL
,	NULL
Wojchowski	NULL
DM	NULL
:	NULL
Functional	NULL
interaction	NULL
of	NULL
GATA1	NULL
with	NULL
erythroid	NULL
Kruppel-like	NULL
factor	NULL
and	NULL
Spl	NULL
at	NULL
defined	NULL
erythroid	NULL
promoters	NULL
.	NULL

Blood	NULL
87:1793	NULL
,	NULL
1996	NULL
34	NULL
.	NULL

Fischer	NULL
KD	NULL
,	NULL
Haese	NULL
A	NULL
,	NULL
Nowock	NULL
J	NULL
:	NULL
Cooperation	NULL
of	NULL
GATA-1	NULL
and	NULL
Sp1	NULL
can	NULL
result	NULL
in	NULL
synergistic	NULL
transcriptional	NULL
activation	NULL
or	NULL
interference	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:23915	NULL
,	NULL
1993	NULL
35	NULL
.	NULL

Crossley	NULL
M	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Phosphorylation	NULL
of	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:16589	NULL
,	NULL
1994	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1998	NULL
92	NULL
:	NULL
2436-3444	NULL
Differential	NULL
Regulation	NULL
of	NULL
Coproporphyrinogen	NULL
Oxidase	NULL
Gene	NULL
Between	NULL
Erythroid	NULL
and	NULL
Nonerythroid	NULL
Cells	NULL
Shinichiro	NULL
Takahashi	NULL
,	NULL
Shigeru	NULL
Taketani	NULL
,	NULL
Jun-etsu	NULL
Akasaka	NULL
,	NULL
Akira	NULL
Kobayashi	NULL
,	NULL
Norio	NULL
Hayashi	NULL
,	NULL
Masayuki	NULL
Yamamoto	NULL
and	NULL
Tadashi	NULL
Nagai	NULL
4	NULL
QM	NULL
“	NULL
Caw	NULL
,	NULL
.	NULL

,	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

2	NULL
YOtow®	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/92/9/3436.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Red	NULL
Cells	NULL
(	NULL
1159	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

